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ABSTRACT 
Polyaromatic hydrocarbons (PAHs) are ubiquitously present in the environment and 
have deleterious affects on humans. Cytochrome P450 enzymes have been found to be 
useful in the biodegradation of the PAHs through an initial hydroxylation step. This 
makes them more water-soluble and accessible to the action of other oxidases. 
Cytochrome P450cam is a model P450 enzyme that has been mutated for enabling PAH 
and alkane hydroxylation. P450s therefore have potential for use in commercial process 
for production of primary alcohols.  
Rhodococcus organisms have a special mechanism for transporting the hydrophobic 
hydrocarbons into their cells. Cloning of the P450cam gene into Rhodococcus can potentially 
provide a hydroxylation system with high conversion rates. To enable this, cytochrome 
P450cam gene (CYP101) was cloned into a Rhodococcus-Escherichia coli shuttle vector. This 
would provide tools to modify the gene and target specific PAHs. This study is aimed at 
developing a Rhodococcus-based biocatalyst using cytochrome P450 enzymes.  
The cytochrome P450cam gene was synthesized using PCR (polymerase chain reaction); 
the product was cloned into pKSD6-1 (a Rhodococcus-Escherichia coli shuttle vector) and 
transformed into Escherichia coli. The recombinant protein in Escherichia coli was produced 
by induction and the protein extract was analyzed using spectrophotometric analysis, 
camphor binding and carbon monoxide binding assays. 
The results showed a Soret band at 414nm but no carbon monoxide or substrate binding 
was observed. The control culture grown under similar conditions with only the pKSD6-
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1 gene did not show any absorption band at 414nm. These results together indicate that 
the gene has been cloned into the recombinant plasmid, but the enzyme being produced 
might be in an inactive form. 
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C h a p t e r  1  
  INTRODUCTION 
1.1 Background 
Proteins are the molecular instruments through which the genetic information 
is expressed. They are the most abundant biomolecules and are diverse in 
their functions. Enzymes are highly specialized proteins and are central to 
every biochemical process; they serve as reaction catalysts of the biological 
systems. Enzymes are more desirable than their chemical catalysts because of 
their superior catalytic power, high degree of specificity for their substrates 
and their ability to function in aqueous solutions under mild conditions of 
temperature and pressure. These properties of the enzymes have led to 
important applications in the fields of medicine, chemical industry, food 
processing and agriculture. [1] 
Oxygenases are enzymes that catalyze oxidative reactions in which the oxygen 
atoms are directly incorporated into the substrate molecule forming a new 
hydroxyl or a carboxyl group. Among these are dioxygenases, which catalyze 
reactions in which both the oxygen atoms are incorporated into the organic 
substrate molecule and monooxygenases, that are more abundant in nature, 
catalyze reactions in which only one of the oxygen atoms is incorporated into the 
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substrate while the other is reduced to water. The main substrate accepts one of 
the oxygen atoms and the co-substrate furnishes the Hydrogen atom to reduce 
the other oxygen atom. The general reaction catalyzed by the monooxygenases is 
OHBOHAOOBHAH 22 ++−→−++                     (1) 
In the above equation AH is the main substrate and BH2 is the co-substrate. 
Monooxygenases are also known as hydroxylases as they catalyze reactions in 
which the main substrate becomes hydroxylated. They are also known as mixed 
function oxidases or mixed-function oxygenases to indicate that they oxidize two 
different substrates simultaneously. The co-substrate used by the 
monooxygenases is a reduced flavin nucleotide such as FADH2 or FMNH2, some 
enzymes use NADH or NADPH while a very few use α-ketoglutarate. [1] 
A type of heme protein called cytochrome P450 (CYP) catalyzes a vast number 
of very complex monooxygenation reactions. It is capable of catalyzing the 
oxidation of the C-H bonds to alcohol functionality. The P450 enzymes have the 
ability to selectively oxidize an array of endogenous and exogenous organic 
compounds ranging from medium chain alkanes such as n-heptane and n-octane 
to steroidal, polyaromatic and very large molecules such as triterpenes without 
further oxidation to aldehydes and ketones. This is therefore a novel alternative 
to the industry where all current alkane oxidation processes use elevated 
temperatures and pressures and metal oxide catalysts, which do not have the 
required activity, selectivity or specificity. [2] 
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All heme proteins consist of a porphyrin ring, which binds the iron atom. 
Porphyrins are planar ligands with a central ring structure and various substituent 
groups at the edges of the ring as shown in Figure 1. The central ring structure of 
the porphyrins consists of four pyrrole rings and the structure of a pyrrole ring is 
shown in Figure 2. Heme is a metalloporphyrin with the complex organic ring 
structure of a protoporphyrin with the iron atom bound in its ferrous (Fe2+) state. 
Metalloporphyrins, contain a metal atom bound to a porphyrin and are 
synthesized naturally and utilized biologically as redox catalysts. These 
metalloporphyrins possess characteristic absorption spectra that can be used for 
identification and quantitative estimation of the porphyrins and porphyrin bound 
compounds. These metal complexes are incorporated into many proteins as 
prosthetic groups. Within the protein framework the prosthetic group is a 
versatile tool with highly specialized functions. 
Heme serves as a prosthetic group among various classes of proteins such as the 
globins, catalases, hydrogen-binding peroxidases, cytochrome P450 etc. As seen 
in the Figure 3 the iron atom of the heme has six coordination bonds, four to the 
nitrogen atoms of the porphyrin ring system and two, perpendicular to the plane 
of the porphyrin .The unique C-H activation activity of cytochrome P450 has no 
equivalent in classical synthetic methodologies. 
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 Figure 1: Structure of porphyrin 
 
Figure 2: Structure of Pyrrole Ring 
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 Figure 3: Structure of Heme 
 The electron-donating nitrogen atoms to which the iron atom is bound in the 
heme prevent the oxidation of the iron to ferric state thereby preserving its 
reversible oxygen binding capacity. This is one of the reasons why the heme 
group is embedded deep inside the proteins that contain it. They also generally 
have a His (Histidine) residue occupying one of the coordinate bonds leaving 
only one site for the oxygen to bind. Small molecules such as carbon monoxide 
(CO) and Nitric oxide (NO) coordinate to the heme iron with an affinity greater 
than that of oxygen. [1] 
Among the cytochrome P450 enzymes, cytochrome P450cam was the first P450 
enzyme to be structurally characterized and has been studied in detail. 
Cytochrome P450cam from the soil bacterium Pseudomonas putida is responsible for 
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the stereo specific methylene hydroxylation of camphor as the first step in the 
compound’s catabolism when used as the sole carbon source. Cytochrome 
P450cam is a soluble enzyme that is obtainable in relatively large amounts with a 
high purity. It has been used extensively as a model to investigate the chemical 
and biophysical mechanisms of P-450 dependent mechanisms. [2]  
It has been shown that cytochrome P450cam can be engineered to oxidize many 
different classes of compounds that are structurally unrelated to its natural 
substrate camphor. Increasing the hydrophobicity of the active site in P450cam by 
random mutagenesis is shown to increase its activity towards hydrophobic 
molecules that are both smaller than camphor like simple alkanes and larger ones 
such as naphthalene and pyrene. [3] 
Polycyclic aromatic hydrocarbons (PAHs) are hazardous and are persistent in the 
environment. They are procarcinogens and their carcinogenicity is expressed by 
their oxidation by the human cytochrome P450 enzymes such as CYP1A1. The 
inability of the PAHs to be soluble in water and the lack of naturally occurring 
microbial enzyme systems for their efficient degradation are the reasons for their 
persistence in the environment. Initial oxidation by the P450 monooxygenases 
and non-heme dependent dioxygenases has been reported to be the probable 
rate-limiting step after the microorganism sequesters the PAHs. All the P450 
enzymes follow the same mechanism of generating the ferryl intermediate 
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species, which attacks a variety of substrates. This combined with the fact that 
P450 enzymes are involved in the PAH carcinogenesis of the mammals and the 
PAH bioremediation by the microorganisms provides reason enough to 
investigate methods which will enable the use of these enzymes to degrade the 
PAHs. [3]  
1.2 Overview 
This section introduces objective, concept and experimental philosophy of the 
cloning of the cytochrome P450cam gene into the Rhodococcus-Escherichia coli shuttle 
vector pKSD6-1 (obtained from Peter C.K. Lau and Matthew J. Grossman, 
Biotechnology Research Institute, National Research Council, Quebec, Canada). 
The basic idea behind cloning cytochrome P450cam into a Rhodococcus-Escherichia coli 
shuttle vector is to produce the camphor-binding enzyme in the new host 
Rhodococcus and modify the enzyme genetically using random mutagenesis so that 
the enzyme will be able to act on polycyclic aromatic hydrocarbons and in the 
production of primary alcohols. This involved firstly cloning the recombinant 
pKSD6-1 +CYP101 plasmid into Escherichia coli and then transforming it into 
Rhodococcus.  
The hydrocarbon-degrading enzymes are a part of the cytoplasmic membrane 
system, so the hydrocarbon substrate has to be transported through the 
hydrophilic cell wall into the cell to be metabolized. This step of hydrocarbon 
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intake is strongly limited by the hydrophobic character of these substrates. 
Rhodococcus is one of the organisms that are able to utilize hydrocarbons; it is able 
to do so by changing the physical-chemical character of its cell wall by inserting 
amphiphilic molecules into its surface layers thereby assuring the efficient 
transport by a strong cell attachment to the hydrophobic substrate. [4] 
Rhodococcus organism therefore has an extraordinary capacity for metabolizing 
recalcitrant organic compounds and has a demonstrated solvent tolerance, which 
make it a suitable host for cloning CYP101. The full exploitation of Rhodococcus is 
limited by the lack of genetic tools for manipulating the organism. The lack of 
such knowledge in Rhodoccocus is compensated by the extensive knowledge on the 
genetics and the molecular biology of Escherichia coli, which provide all the 
necessary tools to facilitate its use while performing random mutagenesis to 
create a biocatalyst, which can act on substrates other than camphor. [5] 
Cloning of the cytochrome P450cam gene into the Rhodococcus-Escherichia coli shuttle 
vector pKSD6-1 consisted of producing the gene from pcWoriP450cam plasmid by 
polymerase chain reaction (PCR), cloning the gene into the commercially 
available pCR2.1 TOPO vector (Invitrogen Corporation, Carlsbad, CA), 
obtaining the CYP101 gene from the recombinant Topo+CYP101 plasmid 
ligating it with the pKSD6-1 plasmid and transforming it into Escherichia coli. 
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Analysis of the pKSD6-1 plasmid showed that cloning the CYP101 gene from 
the plasmid pCWori+CYP101 into pKSD6-1 was not a feasible task because of 
the unavailability of appropriate restriction sites to directly insert the gene into the 
vector. It was therefore essential to use an intermediate vector, in this case the 
commercially available pCR2.1 TOPO in order to achieve this end. The CYP101 
gene was produced from the pCWori+CYP101 plasmid using Polymerase chain 
reaction using primers P450 1F and P4501R that were designed based on the 
standard design conventions stated in Sambrook Cloning Manual. [6] 
The PCR product of CYP101 gene was analyzed using gel electrophoresis and the 
gene was cloned into the pCR2.1 TOPO vector and transformed into the 
Top10F’ chemically competent Escherichia coli cells (Invitrogen, Carlsbad, CA). 
Among the various positive clones the one which yielded the CYP101 gene (1.4 
kbp size fragment) upon restriction analysis was selected. This recombinant 
plasmid was named 3-TOPO+CYP101.   
The sequence of CYP101 that was amplified using P4501F and P4501R primers 
was inserted into the gene sequence of the commercially available pCR2.1 TOPO 
and a recombinant gene sequence of the 3-TOPO+CYP101 was created. This 
recombinant gene sequence was analyzed using the NEBcutter V2.0 tool for the 
appropriate restriction sites to clone the CYP101 gene into pKSD6-1. 
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Upon analysis, the ApaI site was found to be the most suitable site for use in 
both the vector and the insert. Both the vector pKSD6-1 and the plasmid 
containing the insert 3-TOPO+CYP101 were restricted with ApaI to get the 
desired “sticky” ends. The recombinant cytochrome P450cam and pKSD6-1 was 
then transformed into Escherichia coli (DH5α) cells and a positive clone was 
isolated. The double resistance of pKSD6-1 to ampicillin and chloramphenicol 
antibiotics was used in selecting the positive clone. 
The positive clone containing the recombinant CYP101 and pKSD6-1 was grown 
and the cytochrome P450cam enzyme production was induced in the cells using 
IPTG (Isopropyl β-D-thiogalactopyranoside). The protein extract from the cells 
was analyzed using spectrophotometry, camphor binding and carbon monoxide 
binding assays. These analyses revealed that the CYP101 gene has been cloned 
into the pKSD6-1 shuttle vector and the enzyme that was produced was in its 
inactive form. This present work is a detailed compilation of the experimental 
procedures undertaken and analysis of the results. 
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C h a p t e r  2  
LITERATURE REVIEW 
2.1 Cytochrome P450  
Background 
Cytochrome P450 enzymes are a family of b-type heme containing proteins, their   
ubiquity is evident by their presence everywhere in nature from Archaebacteria to 
humans with the exception of enterobacteria. As of January 18, 2004 the number 
of named cytochrome P450s include 1277 animal sequences, 1098 plant 
sequences, 207 lower eukaryote sequences and 461 bacterial sequences. 
That is a total of 3043 different named sequences and there are many more to be 
named. [7,8] 
The name P450 was given to indicate a pigment (‘P’) with a heme Fe2+-carbon 
monoxide complex having an absorption spectral band at 450nm. The 
cytochrome P450 enzymes catalyze monooxygenation of a number of aromatic 
and aliphatic compounds in numerous metabolic and biosynthetic pathways. In 
the biodegradative pathways of the eukaryotes they are responsible for the 
metabolism of most xenobiotics as well as pharmaceuticals. This is important 
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because though the oxidation of the xenobiotics is a prelude to their excretion 
sometimes they get converted into reactive metabolites that cause deleterious side 
effects. [9,10] 
 In plants they play active roles in herbicide resistance and biosynthetic pathways 
such as morphine biosynthesis, in fungi they are involved in the antibiotic 
synthesis; they synthesize resistance to plant toxins in insects and in the metabolic 
and synthetic pathways of bacteria. The most common reaction catalyzed by the 
cytochrome P450 is hydroxylation but forms that catalyze epoxidation, 
dealkylation and sulfoxidation are also known. The P450 reaction generally 
requires two electrons (which are provided by its redox partner), dioxygen and 
two protons. [7] 
There are three classes of P450 systems (shown in Figure 4); Class I are three 
component protein systems in which the redox partners consist of NADH-
dependent FAD containing ferredoxin reductase and ferredoxin, examples of the 
class I P450s are most bacterial and all eukaryotic mitochondrial P450s. Class II 
P450 systems such as the eukaryotic microsomal (like those associated with the 
endoplasmic reticulum) are two component systems in which the redox partner is 
the NADPH-dependent diflavin (containing FAD and FADH) reductase. Class 
III consists of a single component, which is a fusion of both the components, 
representative of such a system, is the bacterial P450BM3. [7] 
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Figure 4: Various classes of P450 systems. [7] 
 
 
 
 
 13
Reactions catalyzed by Bacterial P450s  
P450s contain an obligate heme cofactor that is linked to the peptide backbone of 
the protein via a thiolate ligand provided by a cysteine residue. This cofactor 
allows the enzyme to activate molecular oxygen to produce a high valent iron-oxo 
species that is a powerful oxidant and enables these enzymes to perform a range 
of oxidative transformations. Differences in the substrate specificities of the 
various P-450s come from the different peptide backbones. Escherichia coli and 
Salmonella typhymurium contain no P450s at all. The Table 1 lists the various types 
of reactions catalyzed by the bacterial P450 enzymes, the species of their origin 
and the various substrates they act upon. [11] 
Comparison of the bacterial and mammalian cytochrome P450s 
Rheinwald and Gunsalus (in 1973) were the first to show that the genetic 
information for the proteins involved in camphor degradation is located on a 
plasmid. There are some similarities between the membrane bound mammalian 
mitochondrial steroid hydroxylating systems such as CYP11A1, CYP11B1, 
CYP11B2 and the bacterial CYP101 systems. The mammalian systems receive 
reduction equivalents from NADPH via membrane–associated adrenoredoxin 
reductase (AdR) and adrenodoxin (Adx), a soluble [2Fe-2S] cluster containing 
ferredoxin while the CYP101 system receives NADH via an FAD-containing 
putidaredoxin reductase (PdR) and a [2Fe-2S] cluster-containing ferredoxin,  
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Table 1: Reactions catalyzed by 
bacterial P450s [11] 
Enzyme Gene Original Host 
Organism  
Reaction catalyzed Substrate  Product 
P450cam CYP101 Pseudomonas putida Stereo specific 
hydroxylation 
(1R)-(+)-
camphor 
5-exo-
hydroxycam
phor 
P450terp CYP108 Pseudomonas species Stereo selective 
hydroxylation 
α-terpineol  
P450lin CYP111 Pseudomonas species Stereo selective 
hydroxylation 
Linalool  
P450cin CYP176
A1 
Citrobacter braakii Stereo selective 
hydroxylation 
Cineole  
P450camr  Rhodococcus sp   (1R)-(+)-
camphor 
6-endo 
hydroxycam
phor 
P450PicK CYP107L
1 
Streptomyces venzuelae 1. Hydroxylation 
Of the C-10 and/or C-12 
position . 
2. Dehydroxylation 
of the 12-
membered 
macrolide at C-10 
position followed 
by the 
hydroxylation at 
the C-12 position. 
 
Macrolides Methymycin 
Neomethym
ycin 
Novamethy
mycin 
14-
membered 
macrolide 
,picromycin 
 
P450NovI  Streptomyces spheroids 
Streptomyces niveus 
Hydroxylation  L-tyrosine 
β-
hydroxytyros
ine 
Thermop
-hilic 
P450 
CYP119 Sulfolobus solfataricus Hydroxylation Long-chain fatty 
acids 
 
P450BM
3 
CYP102
A1 
Bacillus megaterium Hydroxylation Long chain fatty 
acids 
 
P450Eth
B 
 Rhodococcus ruber Bioremediation of 
industrial wastes by 
hydroxylation. 
Methyl and ethyl 
t-butyl etherand 
methyl t-pentyl 
ether. 
 
P450sca  Streptomyces carbophilus Lowering cholestrol by 
Hydroxylation using 
pravastatin 
cholestrol  
P450EpoK  Sorangium 
cellulosumSMP44 
In vitro epoxidation Epithilone D  Epithilone B 
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putidaredoxin. Figure 5 shows a schematic presentation of the soluble bacterial 
CYP101 system and of the mammalian mitochondrial CYP11A1 system. Arrows 
indicate the possibility of transferring of first electron to the heterologous P450. 
[10] 
Though the electrons can be transferred to a heterologous P450 (i.e. CYP101 or 
CYP11A1) by putidaredoxin and adrenodoxin, the ferredoxins in the systems 
cannot substitute for each other. Even though the ferredoxins cannot substitute 
each other it has been shown that a system containing PdR, Pdx and microsomal 
P450 CYP2B4 converts substrate effectively. Observed reaction rates of both the 
systems range from 300 per minute for the CYP101 to 100 per minute for the  
 
Figure 5: Electron transfer systems in CYP101 and CYP11A1 [10] 
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CYP11A1, (catalyzes the first step in the conversion of cholesterol to 
prenenolone). The difference in the reaction rates can be attributed to the 
different velocities, which are the defining point of the fast bacterial and the slow 
mammalian P-450 systems. [10] 
Primary structures of the two ferredoxins reveal a 40% structural similarity with 
38 identical amino acids and 18 conservative substitutions. When the primary 
structures of both the ferredoxins are aligned, the [2Fe-2S] cluster-coordinating 
residues that consist of four residues in both the proteins are found at the same 
relative positions. Both Adx and Pdx are examples of vertebrate-type ferredoxins 
and their tertiary structure reveals the same overall topology. The Figure 6 gives  
 
 
Figure 6: 3D structures of Adx (top) 
and Pdx (bottom). [10] 
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the 3D structures of Adx and Pdx. Interaction sites of the mitochondrial 
cytochrome P-450s are different than those of the CYP101. There is a major 
difference in the C-terminal of both the ferredoxins, Adx has an extended C-
terminal region and it does have an aromatic residue, which is the very important 
W106 (Tryptophan) in Pdx. These are a few of the differences and similarities 
between the two P-450 systems. [10] 
Properties  
Crystalline P450cam contains one heme per 46,000 molecular weight; it has one 
mole of aspartate or asparagines as its NH2 (amino) terminal amino acid. It is 
completely homogenous when examined by electrophoretic mobility and 
hydrodynamic properties. It gives a single protein band over a pH range of 4.0 to 
8.8 in a cellulose acetate strip electrophoresis. It has an isoelectric point at a pH of 
4.7. Molecular weight of P450cam varies between 44,000 and 46,000. The purified 
P450cam possesses a single molecule of ferriprotoporphyrin IX (heme) as a 
prosthetic group. The heme can be removed by several methods and the 
apoprotein thus obtained can be reconstituted to active P450cam with a 
commercial or 57Fe-replaced heme. [12] 
The α and β bands of oxidized form of P450cam shows absorption spectra at 571 
and 538nm respectively. The Soret band is at 417nm; a shoulder or γ band is at 
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365nm, the aromatic amino acid content at 280nm with a shoulder at 290nm. 
Reduction of P450cam with dithionite causes a shift in the Soret band from 417nm 
to 411 nm, the α and β bands are fused into a single absorption band at 540nm. 
The amount of active P450cam in the sample is directly proportional to the Soret 
absorption band. [12] 
Reduced P450cam reacts with carbon monoxide to form a complex and causes the 
Soret maximum to shift to 446nm; the α and β bands are fused at 550nm. 
Carbon monoxide doesn’t alter the absorption spectra of the ferric (oxidized) 
P450cam. Cytochrome P450cam is stabilized by the addition of camphor both 
during purification and storage. [12] 
 Camphor free enzyme solutions show a gradual loss of enzymatic activity on 
storage for long periods of time compared to the camphor bound ones. The 
camphor bound enzymes are more stable because the binding of camphor the 
enzyme’s natural substrate helps it preserve its tertiary structure. Lower protein 
concentrations augment the loss in enzymatic activity. Camphor bound enzyme 
has absorption maxima at 280, 392 and 643 nm. Addition of dithionite to an 
anaerobic solution reduces the heme and the spectral maxima shift to 409nm and 
545nm. When carbon monoxide is bubbled through the reduced enzyme, it 
results in the absorption maxima to 446nm and 552nm. [12, 13] 
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Phenylimidazoles inhibit P450cam activity at low concentrations and replace the 
substrate. DPNH (diphosphopyridine nucleotide dehydrogenase) and KCN 
(Potassium Cyanide) at high concentrations are inhibitory to the enzyme. In the 
absence of camphor, a high concentration of DPNH causes permanent damage 
to P450cam that is irreversible. In the presence of camphor P450cam is slowly 
reduced by camphor. Activation of P450cam by glycerol is directly proportional to 
its concentration. Sulfhydryl compounds such as cysteine, homocysteine, and 
thioglycolic acid, glutathione and cystathione increase the activity of the enzyme 
which probably is due to the conversion of the small amounts of enzymatically 
inactive P-420 present to P-450cam. [12] 
Crystal Structure 
Crystals obtained from the ammonium sulfate solutions in the orthorhombic II 
form provide good details about the structure of the enzyme. P450cam is an 
asymmetrically shaped protein resembling a triangular prism of approximately 30 
Ǻ with a maximum dimension of 60 Ǻ. There are twelve helical segments labeled 
from A to L which dominate the structure and account for ~45% of the residues. 
Four anti-parallel β pairs make up about 15% of the structure. There are no 
parallel β pairs or extended sheet structure. The helices are arranged in three 
layers stacked on top of one another and the heme is embedded in the layers. The 
regular triangle shape of the enzyme is a result of the efficient packing of four 
molecules in a unit cell; a reason for the low water content of the crystals. [14] 
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The helices E, F, G, I form an antiparallel Greek key helical bundle; a common 
structural motif found in globins, cytochrome c, etc. Helices L and I are almost 
parallel to one another; helices D and L are also in approximate parallel 
alignment. The remainder of the structure is a mix of helices interspersed with β 
pairs. The number of residues in helical conformation is equal in the N and the C 
terminal halves of the molecule while majority of the β structure is in the C 
terminal domain. [14] 
The heme is located between the proximal L helix and the distal I helix. The 
proximal helix runs along the molecular surface while the distal helix runs 
through the center of the center of the molecule. The heme is approximately 8Ǻ 
away from the surface but it is not exposed to the bulk solvent. The hydrogen 
donors such as Arg112, Arg299, His35, Gln108, Asp297 and a water molecule 
surround the heme propionate groups. One of the heme propionate groups 
forms an unusual interaction of carboxyl-carboxyl hydrogen bond with the side 
chain of Asp297 and the Arg299 forming an ion pair with the propionate with its 
guanidium group only 4.0 Ǻ away from the Asp297 carboxyl group, its positive 
charged counterion thus aiding in stabilization of the carboxyl-carboxyl hydrogen 
bond. [14] 
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Catalytic cycle of cytochrome P450cam 
Cytochrome P450cam (CYP101) catalyzes the insertion of one oxygen atom from 
O2 into camphor thereby converting it into 5-exo- hydroxycamphor; this is the 
first step in the camphor catabolism by the soil bacterium Pseudomonas putida. 
There are two electrons required for the camphor hydroxylation by CYP101, 
which come from the oxidation of NADH, which is in turn catalyzed by 
putidaredoxin reductase (PdxR). A Cys4Fe2S2 ferredoxin, putidaredoxin (Pdx) 
shuttles the electrons from PdxR to CYP101. [15] 
The catalytic cycle of Pseudomonas putida P450cam (as shown in Figure 7) consists 
of reversible substrate binding, which converts the six-coordinate, low-spin met 
form of the protein to the five-coordinate, high-spin FeIII camphor complex, 
thereby increasing the reduction potential of the heme iron atom. The addition 
of the first electron reduces the enzyme to the five-coordinate FeII camphor 
complex. Oxygen binds to the five-coordinate FeII camphor complex and gives 
the six-coordinate ferrous-dioxy (FeII-O2) intermediate. Addition of a second 
electron and two protons followed by cleavage of the oxygen-oxygen bond 
produces a molecule of water and an oxidizing species, the so-called activated 
oxygen intermediate; and insertion of the iron-bound oxygen into the substrate 
produces 5-exo-hydroxycamphor and product is released. [16] 
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Figure 7: Catalytic cycle of Pseudomonas 
putida P450cam [17] 
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Putidaredoxin reductase and Putidaredoxin  
There are two types of electron transfer systems associated with 
monooxygenation reactions catalyzed by P-450s 1) those requiring a flavoprotein 
dehydrogenase, an iron-sulfur protein, and the P-450; and 2) those requiring a 
FAD and FMN containing flavoprotein dehydrogenase and the P-450. An 
example of the former class is P-450cam and they are usually associated with 
mitochondrial steroidogenesis, while the latter is associated with microsomal drug 
or steroid metabolism and P-450BM3. P-450cam has been cloned, sequenced, and 
expressed in an active form in E. coli thereby providing a useful tool for studies of 
the electron transfer and monooxygenation reaction utilizing site-directed 
mutagenesis. [18] 
Active site mutants of CYP101 have been shown to oxidize a wide range of 
compounds. CYP101 activity requires two proteins, a flavoprotein putidaredoxin 
reductase (PdxR) that accepts two electrons from NADH and one at a 
timetransfers these to cytochrome P450cam through the mediation of an iron- 
sulfur protein putidaredoxin (Pdx) whose role is to transfer the electrons from 
NADH cofactor to CYP101 enzyme. [19] 
The Figure 8 illustrates the flow of electrons from NADH to P450cam. In the first 
electron transfer reduced Pdx combines with a ferric-camphor bound P450cam 
and reduces it to the ferrous form. In the second electron transfer the reduced  
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Figure 8: Electron Transport from PdR to P450cam Mediated by Pdx. [20] 
Pdx forms a binary complex with oxyferrous, D-camphor bound P450cam and 
leads to the formation of the products 5-exo-hydroxycamphor, water, oxidized 
Pdx and D-camphor free ferric P450. Pdx plays the role of an ‘effector’ in the 
second electron transfer in addition to being an electron carrier. [19] 
There are three possible mechanisms for the flow of electrons from PdxR to 
P450cam; these include the cluster, Pdx shuttle and the transient cluster 
mechanisms. In the cluster mechanism the PdxR/Pdx/P450cam complex forms 
and survives for one or more turnovers. This indicates that both the electrons 
from one molecule of NADH move through the flavin of PdR to sequentially 
reduce the same Pdx and P450cam molecules. [20] 
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The shuttle mechanism doesn’t require the formation of a complex of all the 
three proteins during the catalytic cycle; it involves the reduction of the oxidized 
Pdxox by PdxR and release of the reduced form of Pdxr into the solution and 
reduction of P450cam by the binding of Pdxr. The transient cluster mechanism is a 
hybrid of the prior two mechanisms. In this one molecule of Pdx remains bound 
to the P450cam throughout one or more catalytic cycles. The cycling of Pdxox to 
Pdxr occurs via a transient association of fully reduced or one electron reduced 
PdR to Pdxox /P450cam complex. Two possible mechanisms for transfer of 
electrons from PdR to P450cam are shown in Figure 9. [20] 
There is evidence in support of the shuttle mechanism which includes the ability 
of PdxR to reduce Pdx in the absence of P450cam and also the fact that Pdxr is 
able to carry out both the electron transfer steps to P450cam in the absence of 
PdxR. In addition mutagenesis studies have revealed that the binding sites on Pdx 
for the PdxR and P450cam overlap, indicating that PdxR and P450cam cannot bind 
simultaneously to Pdx. Though the fusion proteins of PdxR, Pdx and P450cam 
have an efficient turn over, the shuttle mechanism is probably what fits best in 
the overall picture. [20] 
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 Figure 9: Possible mechanisms for 
transfer of electrons from PdR to 
P450cam The oval represents the 
porphyrin ring of camphor-bound 
P450cam [20] 
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Substrate specificity of P450cam 
Cytochrome P450s catalyze a range of oxidative transformations such as carbon 
hydroxylation, heteroatom oxidation, Π (pi) bond oxidation, and hydrocarbon 
desaturation. Despite differences in phylogenetic origin, cellular localization, 
electron donor partners and substrate specificity of P450 enzymes their active 
sites and catalytic mechanisms are remarkably similar. In the catalytic cycle of the 
P450 enzymes, the primary function of the enzymes is to promote the formation 
of ferryl species and to bind and orient the substrate in its proximity. The chemo 
and the regio-specificity of substrate oxidation are determined by the intrinsic 
reactivities of the substrate sites that are accessible to the ferryl species in the 
enzyme substrate complex. [21] 
The oxidation of the organic substrate is caused by the coupled turnover, in 
addition to this the P450 enzymes undergo uncoupled turnover to produce 
oxygen, hydrogen peroxide and water. The uncoupling of the NAD(P)H, 
(chemically reduced form of Nicotinamide Adenine Dinucleotide Phosphate) 
consumption from the organic substrate oxidation is due to dissociation of super 
oxide (O2-*) from the ferrous dioxy complex, and/or reduction of the final ferryl 
species to water by electrons provided by NAD(P)H.  Uncoupled turnover is low 
in resting enzyme but it greatly increases with the binding of some ligands and 
substrates; it is a substrate dependent catalytic process that produces reduced 
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oxygen rather than organic metabolites. Figure 10 shows possible places in the 
Pseudomonas putida catalytic cycle where uncoupling can occur [21] 
The P450 enzymes that have hydrophobic active sites have very broad substrate 
specificity with preference for lipophilic substrates; these facts suggest that the 
binding of the P450 substrates is governed by hydrophobic and steric factors. 
Catalytic turnover is defined as the NADH-and substrate dependent formation of 
either organic or reduced oxygen metabolites. Binding of the substrates to the 
cytochrome P450cam active site is a prerequisite for catalytic turnover. Saturation 
of the active site of P450 cam with camphor results in the complete conversion of 
the enzyme from low spin state to high spin state. 
 
Figure 10: Catalytic cycle of cytochrome P450, showing the individual steps at 
which uncoupling can occur. [21] 
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 Also the binding affinity and the extent to which the enzyme is converted to the 
high spin state by a saturating concentration of the substrate are correlated. 
NADH consumption provides a direct measure of the extent of catalytic 
turnover engendered by the binding of a substrate to P450cam. [21] 
The diversity of the substrates for the P450 enzymes is not only due to the 
multiplicity of the isoforms but because of the fact that they are able to catalyze a 
broad range of P450 dependent transformations with a broad range of substrates. 
It is important to understand the substrate specificities of P450 enzymes for the 
design and construct of P450 enzymes with tailored specificities .The availability 
of the high resolution crystal structures of the four microbial P450 enzymes 
makes the bacterial enzymes amenable to analysis of the features that control 
substrate and reaction specificity. [22] 
Two methods have been used to predict the substrate specificities of the well 
characterized P450cam; one involves the use of molecular dynamic simulations to 
predict the regio-and stereo specificity of the products and the other includes the 
three-dimensional active site constrained screening procedures which are used to 
identify the compounds that fit within the active site and therefore are possible 
substrates. Both these processes necessitate the dissection of the catalytic process 
into discrete steps in order to correlate the effects of structure on individual 
branch points in the process. [22] 
 30
Heavily chlorinated compounds such as chlorinated benzenes such as 
hexachlorobenzene (HCB), pentachlorobenzene (PeCB), biphenyls and dioxins 
are some of the most problematic environmental pollutants. Degradation of the 
most heavily chlorinated benzenes requires initial reductive dehalogenation 
followed by oxidation by the dioxygenase pathway. Pathways that involve 
oxidation of chlorohydroquinones by action of flavin dependent monoxygenases 
degrade polychlorinated phenols. Then these reactive chlorohydroquinones are 
readily dehalogenated by hydrolytic or reductive mechanisms. Ring cleavage in 
polychlorinated benzenes occurs only after most of the chlorines are removed 
resulting in a more facile pathway. Cytochrome P450cam has been genetically 
engineered to act on compounds such as 1,2-DCB (dichlorobenzene), 1, 3-DCB, 
1,4-DCB, 1,3,5-TCB (trichlorobenzene), 1,2,4,5-TeCB (tetrachlorobenzene), 
PeCB (pentachlorobenzene) and HCB (hexachlorobenzene). [23] 
The wild type monooxygenase cytochrome P450cam has a low activity for 
oxidation dichlorobenzene and trichlorobenzene to chlorophenols and no activity 
for heavily chlorinated benzenes. Increasing the active site hydrophobicity with 
Y96F (Tyr to Phe) increased the activity of CYP101 causing the conversion of 
the PeCB and HCB slowly. Also decreasing the space available at the top of the 
active site with the F87W (Phe to Trp) mutation forces the substrate to be bound 
closer to the heme and results in further increase in activity. [23] 
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Cytochrome P450cam has been also engineered to oxidize gaseous alkanes like 
butane and propane to butan-2-ol and propan-2-ol by reducing the substrate-
binding pocket. Using bulky amino acid substitutions reduced the size of the 
substrate pocket and the enzyme-substrate binding was improved. A picture of 
the active site of P450cam is shown in Figure 11. [24]  
Engineering the active site topology for accommodation of different alkanes can 
enhance activity, selectivity and coupling efficiency of alkane oxidation by 
CYP101. Reduction of the active site volume using the mutations Y96F (Tyr to 
Phe)–V247L (Val to Leu) showed a four-fold greater activity for hexane 
compared to 3-methylpentane. When the active site was larger as a result of the 
Y96A (Phe to Ala) –V247A (Valine to Ala) double mutation 3-methylpentane 
was oxidized twice as fast as hexane. [25] 
Styrene was weakly bound to the wild-type P450cam; the binding was strengthened 
in the Y96F (Tyr to Phe) mutant, and again in Y96A (Tyr to Ala) mutant. This 
strengthened binding in mutants is a result of the removal of the hydroxyl group 
of tyrosine to generate a more active hydrophobic site that can interact better 
with styrene. [26] 
Selective catalytic oxidation of simple alkanes under mild conditions is one of the 
more difficult chemical reactions to achieve using conventional synthetic 
methods. Cytochrome P450cam was engineered to oxidize various simple alkanes  
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Figure 11: Active site of the P450cam enzyme with camphor bound in it [24] 
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like hexane, heptane, 2-methylpentane, 3-methyl pentane and 2-methylhexane. 
Since the substrate-binding pocket of cytochrome P450cam is mostly lined with 
hydrophobic residues with the exception of tyrosine 96, this was changed to 
alanine (Y96A) and phenylalanine (Y96F) to suit the hydrophobic nature of 
alkanes. The mutants showed an increased activity towards the alkanes proving 
the fact that increasing the hydrophobicity promotes alkane oxidation. Linear 
alkanes showed higher product formation rates with the Y96F and Y96A mutants 
than the branched ones. [27] 
Polyaromatic hydrocarbons (PAHs) are hazardous and recalcitrant environmental 
contaminants mainly derived from anthropogenic pyrolysis of organic matter 
such as fossil fuel consumption and coal refining processes. These are 
procarcinogens and they are converted into highly carcinogenic oxidation 
products by heme-dependent cytochrome P450 enzymes such as CP1A1.PAH 
oxidation activity of P450 enzymes is of wide interest because P450s are utilized 
in the initial oxidation step of biodegradation of PAHs. [28] 
The cytochrome P450cam has been used to oxidize a variety of unnatural 
substrates. Its mutant Y96A not only increases the hydrophobicity of the 
substrate pocket but also creates space for the binding of substrates larger than 
camphor. These two are important factors that enhance the ability of P450cam to 
act on PAHs. Replacing Y96 with hydrophobic residues like Gly, Ala, Val, Phe 
and further testing the mutants on naphthalene and pyrene have revealed that the 
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mutants oxidize the substrates faster than the wild type. Naphthalene is oxidized 
1- and 2-naphthol via 1,2-oxide intermediate and pyrene gave a 1,6- and 1,8-
pyrenequinone. [29] 
The wild type cytochrome P450cam enzyme has very low activity with polycyclic 
aromatic hydrocarbons like phenanthrene, fluoranthene, pyrene and benzo [a] –
pyrene where as the mutants (with mutations at F87 and Y96) show increased 
activity on the same substrates. Hydrophobic substitutions at Y96 broadens the 
P450cam substrate range through two effects 1) increasing the active site 
hydrophobicity promotes binding of organic molecules and it also reduces 
uncoupling by not favoring the entry of water molecules into the active site 2) 
Y96 also forms a part of the substrate access channel, therefore hydrophobic 
substitutions at this residue may promote binding of hydrophobic molecules like 
pyrene. [29] 
Cloning of the Cytochrome P450cam gene into Escher chia co i i l
Cloning of the cytochrome P450cam gene involved the localizing of the camC gene 
within the PstI and HindIII fragment as shown in Figure 12, this gene is 
responsible for the production of the P450cam enzyme. The primary amino acid 
sequence of P-450cam has a 412 amino acid sequence that corresponds to a gene 
length of 1236bp. Top panel of the restriction map of the 2.2-kilobase pair  
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 Figure 12: Restriction maps of pKG3OO and its derivatives. [3] 
CAM plasmid fragment containing the cytochrome P-450cam gene shows a 
heavy line representing the cytochrome P-450cam gene in Figure 12. The bottom 
panel indicates the various constructions used. Regions between the circles 
represent CAM plasmid DNA, where 0 and 0 are symbols for PstI and HindIII 
sites, respectively. Gene symbols are as follows: tet-tetracycline resistance gene; 
amp-ampicillin resistance gene, 0-lactamase gene; lacZ, β-galactosidase gene. 
Arrows indicate the direction of transcription. [3] 
CAM plasmid was sub cloned into pUC13, pEMBL8+ and pEMBL9+ so as to 
increase the yield of the plasmid DNA because these vectors had a higher copy 
number than their parental vector pBR322 from which pKG300 was derived. In 
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these various sub clones the camC gene was transcribed from the lac promoter, 
thereby increasing the yield of the cloned protein than that produced from the β 
lactamase gene promoter in pBR322. [3] 
The entire cytochrome P450cam gene from the PstI to the HindIII site that was 
1578bp was sequenced; this also included a flanking sequence and some DNA on 
the 3′ end. The Figure 13 shows a heavy line representing the cytochrome P-
450cam gene. Arrows in Figure 13 indicate the direction and extent of sequencing 
from each restriction site. Only restriction sites used for sequencing are shown, 
PstI (P), BglI (Bg), RsaI (R), BamHI (B), EcoRV (E), BstXI (B X), BstEII (BE), 
Sal1 (SI, and HindIII (H). [3] 
 
Figure 13: Sequencing strategy of the cytochrome P-450 gene.[3] 
 37
 Figure 14 shows nucleotide numbering begins with the first nucleotide of the PstI 
site which is 155 nucleotides 5' to the cytochrome P-450cam gene. Amino acid 
numbering begins with the first Thr (Threonine) and the initiating Met 
(Methionine) of the cytochrome P-450cam and putidaredoxin reductase genes, 
respectively. The underlined nucleotides refer to putative Shine-Dalgarno 
sequences. The boxed amino acids and nucleotides indicate differences between 
the protein sequence and the nucleotide-derived amino acid sequence 
 
 Thus the cytochrome P-450cam gene was cloned into Escherichia coli, its amino acid 
and nucleotide sequence were determined and it was demonstrated through 
various analysis that the cytochrome P-450cam enzyme from Escherichia coli and 
Pseudomonas putida is indistinguishable with respect to its optical spectrum, 
molecular weight, catalytic activity and N-terminal sequence. Placement of the 
camC gene behind the lac promoter in Escherichia coli vectors enabled the camC 
gene behind the lac promoter in Escherichia coli vectors enabled the production of 
the enzyme in large quantities. When the gene was oriented opposite of the 
direction of the vector promoter in Escherichia coli, P-450cam protein was 
undetectable by the reduced CO (Carbon monoxide)-difference spectral analysis. 
[3] 
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Figure 14: The complete nucleotide sequence of the cytochrome P-450 gene and 
a 5' portion of the putidaredoxin reductase gene. [3]  
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2.3 Shuttle vectors 
Introduction 
Shuttle vectors consist of double replicons, in which one half of the plasmid 
allows replication in an enteric bacterial host and the other half allows replication 
in any other host from which the other replicative region has been derived. These 
vectors are used in transferring recombinant plasmids from Escherichia coli into 
non-purple Gram (+) bacteria and most eukaryotic hosts. In these shuttle vectors, 
one half of the vector is derived from Escherichia coli specific vectors, the second 
half comes from often small cryptic (but ideally multicopy) replicons, which were 
isolated from the individual host strain; they provide the oriV specific to the host 
from which they were isolated. The two halves are then joined by DNA 
manipulation, which is the reason why this approach is also referred to as double 
replicon strategy. [30] 
Rhodococcus Escherich a coli shuttle vectors - i
The lack of plasmid vectors suitable for use in Rhodococcus has led several groups 
to develop binary vectors, in which extant Rhodococcus plasmid is combined with 
an Escherichia coli plasmid forming a vector that replicates in both cell types. Some 
of these Rhodococcus-Escherichia coli shuttle vectors are given in the Table 2. 
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Table 2: Rhodococcus-Escherichia coli shuttle vectors 
Rhodococcus-
Escherichia coli 
Shuttle vector 
Features  Reference 
pRHK1 Has a cryptic plasmid pRC4, derived from 
Rhodococcus rhodochrous and a vector from 
Escherichia coli with a kanamycin resistance 
gene, pHSG298 
[31] 
pNC9503 Escherichia coli-Rhodococcus erythropolis shuttle 
vector with a unique restriction site for 
XbaI. It has a kanamycin resistance gene and 
a thiostrepton resistance gene .The origin of 
replication is from Rhodococcus rhodochrous 
plasmid pNC903 
[32] 
pNC9501 In addition to all the features in the 
pNC9503 it has two other unique restriction 
sites for KpnI and EcoRI 
[32] 
pRF29 Cointegrate of pRF28 (StuI linearized) and 
pUC13 (SmaI linearized). Has ampicillin 
resistance gene and chloramphenicol 
resistance gene  
[33] 
pMVS301 and 
pMVS302 
Escherichia coli–Rhodococcus shuttle plasmids 
have ampicillin resistance gene from 
pBR322 and thiostrepton resistance gene  
[34] 
pKSD6-1 Rhodococcus-Escherichia coli shuttle vector 
containing ampicillin and chloramphenicol 
resistance genes. 
[18] 
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Construction of the Rhodococcus-Escherichia coli shuttle vector pKSD6-1  
The Rhodococcus-Escherichia coli shuttle vector pKSD6-1 is capable of replication in 
both Rhodococcus and Escherichia coli and it was constructed as a deletion derivative 
of the plasmid containing the sox genes The Rhodococcus sp. strain X309-11-15 was 
used as a source of a 100-kb pSOX plasmid, and Rhodococcus sp. strain X309-10-2 
(referred as 10-2) was the plasmid free derivative of the Rhodococcus sp strain 
X309. [18] 
¾ pSOX∆1(52 kbp in size) was produced as the first deletion derivative of 
the pSOX plasmid by selecting from the electrotransformed 10-2 strain 
using DBT(Dibenzothiophene).Restriction of pSOX∆1 with EcoR1 
produced five fragments, which were selected for the sox containing 
genes using the Southern hybridization test. This pSOX∆1 was 
introduced into 10-2 and further selection on DBT plates resulted in 
pSOX∆2. [18] 
¾ pSOX∆2 was a 42kb fragment, a series of self defined manipulations like 
the self ligation of a 30kb sox containing EcoRI fragment from pSOX∆2 
gave pSOX∆3 which was capable of replicating in strain 10-2. A 
chloramphenicol resistance (Cmr) gene was added to the rightmost 15-kb 
XbaI-EcoRI fragment at the unique EcoRI site of pSOX∆3.To facilitate 
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cloning, both the linearized vector and the XbaI-XhoI DNA fragment 
containing the Cmr gene were blunt ended with dNTPs and Klenow 
DNA polymerase I. [18] 
¾ Digestion with EcoRV and Xba I gave an 18.5-kb fragment which when 
transformed into 10-2 and selection on chloramphenicol plates gave 
several colonies that were analyzed. The analysis revealed the existence 
of two populations of cells one containing the expected 18.5 kb plasmid 
(pSOX∆4) and the other having a 9kb plasmid (pSOX∆5). [18] 
¾ pSOX∆6 was obtained by ligating the 4-kb KpnI fragment to the 3.5 kb 
Cmr gene cassette, which was a blunt end ligation. Screening for the 7.5 
kb pSOX∆6 revealed the deletion of 400bp in one derivative, which was 
named as pSOX∆6-1. The entire process of constructing the deletion 
derivatives is given in the Figure 15   below.  In the Figure 15 the ability 
of each plasmid to replicate (ori) or possess desulphurization activity (sox) 
is shown at the right by the plus and minus signs. Cmr indicates the 
chloramphenicol resistance marker gene derived from pRF29 plasmid 
and --- in Figure 15 is the undefined boundary of deletion. [18] 
¾ pSOX∆6-1 was linearized by SphI and ligated to the Nae I site (within 
the f1 origin) of the pBluescript II KS –plasmid. The pBluescript II KS –
plasmid provides the colE1 replication origin, a multiple cloning site and  
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Figure 15: Construction of the 
deletion derivatives of the pSOX 
plasmid. [18] 
the lacZα reporter gene for screening inserts in Escherichia coli (blue-white 
selection) and Ampicillin resistance (Apr). The resultant plasmid was named 
pKSD6-1. Figure 16 shows the shuttle vector that has been used for sacB 
expression in Rhodococcus strain 10-2, the MCS, multiple-cloning site (expanded 
region).It also shows the  blunt-end cloning of the end-filled 3.8-kb BamHI 
fragment of pUM28 plasmid containing sacB at the EcoRV site. [18] 
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 Figure 16: Construction of the pKSD 6-1 Rhodococcus-Escherichia coli shuttle vector. 
[18] 
2.4 pCWori plasmid 
pCWori+ is a derivative of the plasmid pHSe5, it contains a pBR322 origin of 
plasmid replication, the lac I gene, the β lactamase gene for conferring ampicillin 
resistance and a bacteriophage origin of replication. The transcription and 
translation regions contain a lacUV5 promoter and two copies of a tac promoter 
cassette followed by a translation initiation region derived from the phage T4 
lysozyme gene. This DNA sequence contains a 7 bp Shine-Dalgarno element 
located three nucleotides 5′ of the initiation codon contained within an NdeI 
restriction site. A trpA transcription termination cassette is located downstream 
of the unique 3′ restriction sites.[39] pCW is a plasmid that over expresses the 
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che W protein, it contains the che W gene from the pJL63 plasmid that has been 
introduced into the pHSe5. In pCW the expression is under the control of the 
tac promoter. [35] 
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C h a p t e r 3  
METHODS AND RESULTS 
3.1 Introduction 
The main aim of the project was to clone the CYP101 gene into a Rhodococcus-
Escherichia coli shuttle vector and express the protein in a Rhodococcus bacterium. 
On examining the MCS (multiple cloning site) of pKSD6-1 and sequence of the 
cytochrome P450cam (CYP101) gene, it was found that cloning of the cytochrome 
P450cam gene directly into the chosen vector pKSD6-1 was not possible because 
of the unavailability of compatible restriction sites on the insert and the vector. 
This necessitated the usage of the commercially available pCR2.1-TOPO vector 
as an intermediary. The CYP101 was first cloned into pCR2.1-TOPO, and then 
the CYP101 gene was restricted with a suitable restriction enzyme and cloned 
into pKSD6-1. 
3.2 Production of the gene from pCWori plasmid containing CYP101 using 
PCR 
The pCWori+CYP101 plasmid (Figure 17) was obtained from Prof. Paul R. Oritz 
de Montellano (University of California, San Fransisco, CA). The following 
factors were taken into consideration while designing the primers. The MCS of  
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Figure 17: pCWori+P450cam 
 
the vector pKSD6-1 was observed and all the available sites on that were 
analyzed for suitability. The suitable restriction sites on the MCS met the 
following conditions  
• They were not present anywhere on the insert, i.e. CYP101 sequence 
• They should have sufficient activity in the same NEB buffer that will be 
used while setting up the restriction reaction. 
Using the CYP101 sequence from the gene bank the forward (P450 1F) and the 
reverse primers (P450 1R) were designed with ApaI and Sac I restriction sites 
included in the P4501F and P4501R respectively as they met all the 
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aforementioned conditions. The feasibility of the designed sequences was then 
tested using the primer design link in the Invitrogen website (see [36]) 
The sequences of the designed primers are given below: 
P4501F (5′-3′): TAG GGG CCC ACA ATG ACG ACT GAA ACC ATA CA 
P4501R (5′-3′): CAT GAG CTC AAG CTT TGG ATA GCG GTGG 
The primers were obtained from Invitrogen and their (10pmol/µL) solutions 
were prepared. The PCR for the production of the P450cam gene was optimized 
by setting up seven 30µL PCRs using buffers A, B, C, D, F, J, and N from the 
Invitrogen PCR optimization kit. The protocol for this set of PCRs is given 
below. 
Protocol for the PCR to produce CYP101 
¾ 5X Buffer: 6µL 
¾ Primers  



LrverseprimeRpmolP
LmerForwardpriFpmolP
µ
µ
5.1:)(Re450110
5.1:)(450110
¾ DNA (CYP101 1:50 dilution of 383.25µg/mL): 3µL 
¾  25 mM dNTP: 0.6µL 
¾ Sterile water: 17.1 µL 
¾ Taq Polymerase: 0. 3µL 
¾ Total volume: 30µL mix contents by gently tapping 
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¾ Add Nujol oil: 10µL and mix the contents again by tapping. 
The contents in the PCR vial were run in a thermocycler (Perkin Elmer Cetus 
DNA THERMAL CYCLER, MA), using program files 90, 91 and 18, which 
were programmed as follows: 
¾ File 90: 2.5 min at 94°C 
¾ File 91:  30 cycles of file 91 






Cat
Cat
Cat
o
o
o
72min4
55min2
94min1
¾ File 18:  delay time 10 min at 72ºC 
After all the programs in the thermocycler were completed, then the PCR vials 
were removed and the reaction solution of 30µL was carefully pipetted using a 
manual pipette and placed in another vial. 15µL of each of the PCR reactions 
performed was run on a gel to test the presence of the desired CYP101 band. Gel 
electrophoresis using agarose gel (0.7%) showed the fragment equal in size to the 
P450cam gene, 1.4 kilobasepair (kbp) in six lanes; of these C, B, A, D, F, J were the 
lanes on which the gene was seen better (in that order as seen in Figure 18) than 
on others. The gene was excised from the gel using a clean sterile blade and DNA 
was extracted from the gel using Wizard PCR preps DNA purification system 
(Promega, CA). Both the insert and vector DNA were restricted with ApaI and 
SacI to get the desired ‘sticky’ ends. The protocol for the restriction reaction is 
given in Table 3. 
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5.1kbp
1.4 kbp
1        2    3    4     5   6     7    8
Lane  Sample
1      Lambda HindIII /EcoRI
2      PCR product using Buffer A
3 PCR product using Buffer B
4      PCR product using Buffer C
5      PCR product using Buffer D 
6      PCR product using Buffer F
7      PCR product using Buffer J
8      PCR product using Buffer N
 
 
 
 
 
 
Figure 18:Gel showing the 1.4 kbp P450 gene from the PCR optimization 
buffers. 
 
Table 3:Protocol for the restriction reactions of insert and 
vector 
Insert Vector 
DNA (from C, D and A): 10µL 
ApaI* (10000u/ml): 1µL 
SacI *(20000u/ml): 1µL 
NEB4* (10X): 3µL 
BSA* (100X): 0. 3µL 
Sterile water: 14.7µL(for PCR products)
Total: 30µL 
3.83µg/mL Vector DNA: 2µL 
ApaI(10000u/ml): 1µL 
SacI(20000u/ml): 1µL 
NEB4 (10X): 3µL 
BSA (100X): 0. 3µL 
Sterile water: 22.7µL(for vector DNA)
Total: 30µL 
*All the restriction enzymes and buffers used for the reactions were obtained 
from the New England Biolabs, MA. 
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3.3 Attempt to directly clone cytochrome P450cam into pKSD6-1 
Since the complete restriction map of the vector pKSD6-1 was not known, the 
experiments were devised on the basis of the available partial restriction map of 
pKSD6-1. The DNA of the PCR products that was run and purified from the gel 
and the vector DNA (pKSD6-1) were restricted with ApaI and SacI enzymes 
The contents were mixed and placed in an incubator at 37°C overnight; the next 
day they were subjected to gel electrophoresis. The insert gave the desired single 
fragment of 1.4kbp but the vector gave three bands instead of the expected one 
10.1kbp band (seen in Figure 19). It was therefore concluded that ApaI + SacI 
together had three restriction sites on the pKSD6-1 plasmid. It was necessary to 
investigate the number of restriction sites for each of the enzymes ApaI and SacI 
so as to determine which restriction enzyme was cutting the vector more than 
once to omit its use further during experimentation; therefore pKSD6-1 was 
restricted with ApaI and SacI separately. ApaI was found have a single restriction 
site on pKSD6-1 at the MCS where as SacI had three restriction sites on the 
entire plasmid (shown in Figure 20) 
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Figure 19: Gel analysis of the insert 
and vector restricted with ApaI and 
SacI 
21 kbp
4.2
3.5
2
1.5
5.1
1.375 kbp
1                         2                    3       4                          5
Lane    Sample 
1         Lambda HindIII/EcoRI
2          CYP101(C) w/ApaI+SacI
3          CYP101 (A) w/ApaI+SacI
4          CYP101 (D) w/ApaI+SacI
5         pKSD6-1 w/ApaI+SacI
 
 
 
 
 
21kbp
5.1kbp
4.2 kbp
1                   3                 5
Lane     Sample
1        Lambda HindIII /EcoRI
2           -
3        pKSD6-1 w/ SacI
4            -
5        pKSD6-1  w/ ApaI
Figure 20: Gel showing the restriction of pKSD6-1 w/ SacI (3) and Apa I (5) 
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Also an attempt was made to construct a partial restriction map of the shuttle 
vector. To this end the vector was digested with different enzymes available in 
the laboratory. The gel analysis of the restriction reactions is given Figure 21. 
3.4 Cloning of cytochrome P450cam into pCR 2.1 TOPO 
 After finding that CYP101 couldn’t be cloned into pKSD6-1 directly using 
current primers/restriction sites; the alternative was to design new primers with 
different restriction sites or to clone via a cloning vector such as commercially 
available pCR 2.1-TOPO. A 50 µL PCR was performed this time different 
restriction sites or to clone via a cloning vector such as commercially available 
pCR 2.1-TOPO.  
 
 
 
 
 
 
21
4.2
3.5
2
1.9
1.5
1.3
0.9 0.8
0.5
5.1
1           2         3     4       5        6        7        8 9       10
Lane      Sample
1         Lambda HindIII/EcoRI
2            -
3            -
4            -
5         pKSD6-1 w/ NdeI
6         pKSD6-1 w/ EcoRI
7         pKSD6-1 w/ HindIII
8         pKSD6-1 w/ XhoI
9         pKSD6-1  w/ NotI
10       pKSD6-1  w/ NcoI
Figure 21: Gel analysis of pKSD6-1 restricted with various enzymes. 
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A 50 µL PCR was performed this time using only buffer C  (that produced the 
clearest band on the gel) for the production of the CYP101 gene; also another 
PCR was set up for the control DNA given in the cloning kit. The control PCR 
was set up as given in the TOPO TA cloning 
Protocol for the 50µL PCR reactions 
¾ Buffer: 10µL 
¾ Primers   



LrverseprimeRpmolP
LmerForwardpriFpmolP
µ
µ
5.2:)(Re450110
5.2:)(450110
¾ DNA (CYP101 1:100 dilution from midi prep): 5µL 
¾ dNTP (2.5Mm): 1µL 
¾ Sterile water: 28 µL 
¾ Taq Polymerase: 1µL 
¾ Total volume: 50µL mix contents by gently tapping 
The products were tested for the presence of the respective genes using gel 
electrophoresis as shown in Figure 22; the P450 band is not very clearly visible in 
the Figure 22. After verification the bands were excised from the gel and purified 
using the Wizard prep PCR purification system.50 µL of each DNA was eluted 
after purification. The purified CYP101 and the control genes thus obtained from 
PCR were cloned into the TOPO cloning vector, pCR 2.1-TOPO and  
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Lane      Sample
1        Lambda HindIII/EcoRI
2         CYP101(C)
3               -
4          Control
21kbp
5.1
2
1.5
1.375kbp
1.4kbp
0.7kbp
1                2           3               4
4.2
 
Figure 22: Gel showing the CYP101 and the control genes 
transformed into Top10F′ cells using the one shot chemical transformation 
protocol given in the TOPO TA cloning manual.  
100 µL of each transformation solution was plated on one LB (Luria broth) agar 
plate (1/10 plate) containing 50 µg/mL ampicillin; the rest of each solution was 
plated on to another one .All the four plates were incubated over night at 37°C. 
The transformation was successful resulting in colonies on all plates. 
 Twenty colonies were picked from the CYP101 transformation containing agar 
plates and two colonies were picked from the control plates and grown in 5mL of 
LB containing 50 µg/mL ampicillin. The colonies were allowed to grow 
overnight in the incubator at 37°C and 150 rpm. The next day, 3mL of each 
culture was used and DNA from the culture was obtained using lysis by boiling 
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method (boiling prep). The size of the recombinant pCR2.1 TOPO+CYP101 
(shown in Figure 23) is 5.4 kbp; this was estimated using the sequences of the 
plasmid pCR 2.1 TOPO and the PCR product CYP101. 
Then this recombinant plasmid was analyzed using NEBcutter V2.0 software for 
a suitable restriction site. The desired site was required to cut the recombinant 
plasmid on the P450cam gene only and linearize the plasmid (Topo+CYP101). 
NotI was the only site that was present once on the TOPO gene and absent on 
the CYP101 gene (as shown in Figure 24), therefore it was chosen to restrict all 
the recombinant DNA isolated from the twenty colonies. 
 
Figure 23: pCR2.1 TOPO+CYP101 plasmid 
 57
  
 
 
Figure 24: pCR 2.1 TOPO+CYP101 
with NotI restriction 
After a two-hour restriction reaction using the standard protocol all the samples 
were analyzed on a gel. The gel revealed an unexpected 3.8 kbp band (shown in 
Figure 25 (a) and (b)) instead of the expected 5.4 kbp. This meant that there was 
no insert in any of the colonies. This fact was further confirmed by restricting the 
recombinant plasmids with EcoRV, which has two restriction sites on the 
recombinant plasmid pCR2.1TOPO+CYP101. 
Another 50µL PCR was set up for the production of the CYP101 gene using the 
protocol given previously. The CYP101 gene formed was verified using an 
agarose gel. To clone the P450 gene into the TOPO vector 4µL of the direct 
PCR reaction mixture was used; it was immediately transformed into Top10F′ 
cells. The transformants were plated on LB agar plates containing 50µg/mL 
ampicillin, X-gal (5-bromo-4-chloro-3-indolyl-bD-galactoside) and 100mM IPTG 
to facilitate blue/white selection. The plates were incubated overnight at 37°C. 
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1 kbp
4.2 kbp 3.8 kbp
1     2   3   4   5    6   7   8  9   10
Lane    Sample
1      Lambda HindIII/EcoRI
2      Colony 1 DNA
3      Colony 2 DNA
4      Colony 3 DNA
5      Colony 4 DNA
6      Colony 5 DNA
7      Colony 6 DNA
8      Colony 7 DNA
9      Colony 8 DNA
10     Colony 9 DNA
                                          
                                     (a) 
 
 
 
 
 
 
                                                             
 1    2    3   4    5    6   7   8    9    10
21kbp
4.2 kbp
5.1kbp
3.8kbp
Lane    Sample
1      Lambda HindIII/EcoRI
2      Colony 10 DNA
3      Colony 11 DNA
4      Colony 12 DNA
5      Colony 13 DNA
6      Colony 14 DNA
7      Colony 15 DNA
8      Colony 16 DNA
9      Colony 17 DNA
10     Colony 18 DNA
 
 
                                         (b) 
 
Figure 25: Gels showing the 3.8kbp band instead of the expected 5.4kbp in the 
DNA isolated from twenty different colonies. 
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• After 24 hrs many colonies were found on each plate. Five colonies from 
each plate were picked and grown in 5mL LB cultures containing 50µg 
/mL of ampicillin. One mL of each of these cultures was stored at-80°C 
in 20% glycerol. The rest of each of the culture was subjected to lysis by 
boiling (adapted from Holmes and Quigley). 
• Using restriction analysis with NotI enzyme, the presence of the insert 
was verified. Gel electrophoresis after restriction analysis revealed the 
presence of the expected 5.4 kbp fragment (seen in Figure 26) on the gel. 
 
  
   
 
 
The expected fragment of 5.4 kbp was seen only in the lanes containing the DNA 
sample from colony 3, which was selected from the agar plates containing the  
 
 
 
 
 
 
 
 
21kbp
4.2
2
1.5 1.3
0.9 kbp
5.1 5.4kbp
1               3
Lane    Sample
1     Lambda EcoRI /HindIII
2        -
3      3-TOPO+CYP101 w /NotI
 
 
 
Figure 26: Gel showing the presence of the 5.4 kbp linear TOPO+CYP101 
plasmid  
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recombinant TOPO+CYP101 transformants thereby proving the presence of the 
gene in the recombinant plasmid of this colony. This colony was grown again in a 
5mL LB culture containing ampicillin and a frozen stock containing 20% glycerol 
was made from this culture using 20% glycerol and was stored at –80°C; this 
stock was named 3-TOPO+CYP101. 
3.5 Cloning of cytochrome P450 from 3-TOPO+CYP101 to pKSD6-1 
A culture of the frozen stock of the 3- TOPO+CYP101 DNA was inoculated 
into 5mL of LB containing ampicillin and was allowed to grow overnight in the 
incubator with a shaker at 225rpm and 37°C. The culture was used as inoculum 
for the 100mL culture containing 50 µg/mL ampicillin that was grown overnight 
on the shaker at 225rpm and 37°C. The DNA was extracted from the 100mL 
culture using midiprep. The presence of the insert was confirmed again by 
restricting 3-TOPO+CYP101 using NotI and EcoRV enzymes (shown in Figure 
27) All the restriction sites in the multiple cloning site of the vector were analyzed 
for an enzyme suitable to act with ApaI for cloning the cytochrome P450cam gene 
from 3-TOPO+CYP101. None of the sites on the MCS of the vector were found 
to be suitable enough to act with ApaI for cloning.  
Also analysis of the 3- TOPO+CYP101 plasmid revealed that there were two 
ApaI sites flanking the cytochrome P450cam gene (shown in Figure 28), therefore 
ApaI was chosen for restricting the cytochrome P450cam gene and ligating into  
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Lane   Sample
1      Lambda HindIII/EcoRI
2          -
3          -
4       3-TOPO+CYP101 w /NotI
5       3-TOPO+CYP101 w /EcoRV
21kbp
4.2
3.5
2
1.91.5
1.30.9
0.8
0.5 kbp
5.1
5.4kbp
0.7kbp
1                                          4            5
4.7kbp
 
 
Figure 27: Gel showing 3- TOPO+P450 w/ NotI and EcoRV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: 3-TOPO+CYP101 plasmid showing ApaI sites flanking the 
cytochrome P450cam gene. 
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pKSD6-1. TOPO+CYP101 with ApaI gave two distinct bands on the gel one of 
1.4 kbp (containing CYP101) and the other 4.0 kbp (shown in Figure 29). 
3.6 Ligation of the insert into the vector 
100µL solutions of the vector (pKSD6-1) and the insert (3-TOPO+CYP101) 
were restricted with ApaI on a 0.7% agarose gel. After an overnight restriction, 
the solutions were subjected to gel electrophoresis to get the desired 10.1-kbp 
vector and 1.4+4.0 kbp insert band (Figure 30). The insert (1.4 kbp) and the 
vector 10.1kbp bands were excised and were using Wizard PCR preps DNA 
Purification Kit (Promega, WI). 50µL of DNA were eluted for each of the vector 
and insert DNA from their respective bands. 
The concentration of DNA was measured in the eluted solutions using 
SPECTRAmax Plus384 (Molecular Devices, Sunnyvale, CA). The amounts of 
DNA present in the vector and the insert solutions were 327.5ng and 
249.75ngrespectively from the calculations based on the absorption spectrum of 
the DNA samples. 
• 300ng of the vector was the basis for the ligation reaction. Depending on 
this the amount of insert required was calculated using the recommended 
1:1 vector-insert ratio. 
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21 kbp
4.2
3.5
2
1.5
1.3  kbp
5.1
4.0 kbp
1.4 kbp
1                                             4
Lane   Sample 
1       Lambda HindIII /EcoRI
2          -
3          -
4        3-TOPO+CYP101 w /ApaI
Figure 29: 3-TOPO+CYP101 with /ApaI restriction  
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21kbp
4.23.5
21.9
1.5
1.3
9 0.8
0.5kbp
5.1
1              2                3              4           5
10.1kbp
4kbp
1.4kbp Lane   Sample
1     Lambda EcoRI/HindIII
2     pKSD6-1 w/ApaI
3     pKSD6-1 w/ApaI
4     3-TOPO+CYP101 w/ApaI
5     3-TOPO+CYP101 w/ApaI
 
Figure 30: Gel with insert and vector DNA. 
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Basis: 300ng vector 
1
1
1.10
8.1300 ××
kbp
kbpngvector      = 53.465ng insert                                 (2) 
The required volumes of the insert and vector were then reduced to much lesser 
volumes in a DNA mini (JOUAN Nordic A/S, Denmark) at 1mbar pressure to 
suit the total required volume of the ligation reaction (10µL). The ligation 
reaction was placed on a vortex for overnight incubation at 4°C. 
The protocol for the ligation reaction is given below 
¾ Vector: 6µL (6.55ng/mL) 
¾ Insert: 2µL (4.995ng/mL) 
¾ T4 ligase: 1µL 
¾ 10X ligase buffer: 1µL 
¾ Total Volume: 10µL 
After vortexing at 4°C overnight the ligation reaction was transformed into 
chemically competent Escherichia coli (DH5α) cells. Transformed 3µL of the 
reaction mixture into three samples of 50µL DH5α cells using chemical 
transformation protocol. The transformants were plated on LB agar plates 
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containing 30µg/mL chloramphenicol and 50µg/mL ampicillin. The plates were 
incubated at 37°C for overnight growth. 
After 24 hrs there were no colonies found on any of the plates. A single white 
colony was observed after 48hrs, which was immediately picked and grown in 
5mL LB containing 30µg/mL chloramphenicol and 50µg/mL ampicillin. Again 
after another 48hr period at 37°C, growth was observed in the test tube. 2mL of 
this culture was stored in 1mL vials with 20% glycerol at -80°C. The remaining 
3mL culture was purified using Wizard Plus Miniprep (Promega, WI). The uncut 
DNA was run on the gel to verify the presence of DNA. No DNA was found on 
the gel. 
• Various attempts to clone the CYP101 from 3-TOPO+CYP101 to 
pKSD6-1 were made after the first one failed. These included ligating the 
vector and insert in ratios of 1:3, 3:1 (vector: insert), increasing the 
quantities of the vector and insert ligated. These were unsuccessful as 
well. 
3.6 Production of the P450cam enzyme 
When the frozen cells that were stocked from the first transformation were 
cultured in 100mL LB containing 30µg/mL chloramphenicol and 50µg/mL 
ampicillin to give another attempt at purifying the gene, it was observed that the 
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culture was pink in color. Purified P450cam enzyme has a brown color and a 
comparison to the color of the recombinant culture indicated that further 
investigation for the presence of the enzyme was needed. 
The cytochrome P450cam enzyme was extracted from the Escherichia coli containing 
the recombinant gene by using the following protocol.  
¾ The Escherichia coli (DH5α) cells were grown to an O.D. (optical density) 
of 0.6 at 37ºC, the flask containing the culture was transferred briefly to 
an incubator at 30ºC for fifteen minutes. Adding 1mM IPTG and 
incubating the cell culture at 30ºC and 90rpm for 36 hours induced the 
production of cytochrome P450cam from the recombinant pKSD6-
1+CYP101 plasmid. 
¾ Then the cells were harvested by centrifuging in the Sorvall RC-5B 
Refrigerated Super speed centrifuge (Dupont Instruments, DE) in an SS-
34 rotor at 13.5K for twenty minutes to obtain the cell mass. Excess 
supernatant was removed from the cells using a pipet. 
• The cell mass obtained: 1.21g 
• Volume of the 50mM Tris HCL added at pH 8.0: 4.84 mL 
• Amount of 0.5mM EDTA added to make an overall 1mM solution: 
9.68µL 
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• 19.36mg of lysosyme (Sigma-Aldrich, MO) was added to this mixture 
and then the mixture was incubated on ice for an hour. After 
incubation the cells were sonicated using Sonicator-Cell disruptor 
Model W-225R (Heat systems-Ultrasonics, Inc. currently known as 
Misonix, Inc, NY). The sonicator settings were as follows: 
9 Stirrer speed: 1.5rpm 
9 Output control on ‘5’ 
9 Time the solution was sonicated for: 1min 
9 Interval between the sonications was for: 45secs 
9 % Duty cycle: 42% 
9 Under these conditions the frequency dial is at 30 
While sonicating the cells the height of the stand on which the beaker was placed 
was adjusted accordingly. The cells for sonication were kept in a test tube in the 
beaker containing ice. Also sufficient care was taken so that the probe was 
immersed in the cell solution but didn’t touch the walls or the bottom of the 
tube. 
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After sonicating the cells 1.382µL (i.e.19.36 u) of Rnase A (QIAGEN, CA) was 
added from a 14u/µL solution to make up a 4u/µL solution. Then 38.72µL of 
2u/µL DnaseI solution was added to the lysed cells containing Rnase A to make 
a 16u/µL DnaseI containing solution. This mixture was stirred at 4°C for an 
hour at a stirrer speed of 4rpm. This mixture was then centrifuged in Sorvall RC-
5B Refrigerated Super speed centrifuge (Dupont Instruments, DE) in an SS-34 
rotor at 13.5K for twenty minutes. 
The centrifuged mixture was removed and the cell extract was carefully decanted 
into another clean sterile 20mL scintillation vial. 50µL of this extract was used for 
spectral analysis. The spectral analysis revealed the presence of an enzyme with a 
peak at 414 nm (as seen in Figure 31). It was confirmed from Figure 31 that a 
heme protein was present. To observe the peaks accurately (as seen in Figure 32) 
the enzyme was further purified using ultra filtration with a 30000 molecular 
weight membrane. 
3.7 Spectral analysis of P450cam after Carbon monoxide binding. 
In order to prove the presence of the P450cam enzyme in the cell extract the first 
and the most important assay is the carbon monoxide binding assay. This assay 
has another special requirement, that the enzyme solution be reduced with 
dithionite anaerobically. Dithionite gets quickly oxidized on exposure to air. Also 
the dissolved oxygen in water can oxidize the dithionite when the required 1mM  
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 Figure 31: Absorbance spectra of the oxidized P450cam 
 
Figure 32: Absorbance spectra of the concentrated P450cam 
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solution is prepared. Therefore it is essential to keep the dithionite oxygen-free in 
all forms and add it to an oxygen-free enzyme solution for the assay to be 
successful. If the enzyme solution is not oxygen free it oxidizes the dithionite and 
produces acid and other oxidation products that denature the enzyme. 
Anaerobic conditions were established in the laboratory by purging the enzyme 
with nitrogen. After a number of trials it was found that this was not sufficient to 
provide the requisite condition, therefore another method was devised for better 
results. A vial of water was crimp-capped, the headspace was vacuumed and was 
purged with nitrogen alternately, and this vacuum-gas method was repeated thrice 
to deaerate the headspace above the water level in the vial. The dissolved oxygen 
in the water was then removed by repeating the same procedure. Thus the water 
was deaerated. This water was used for the purpose of preparing deaerated 
dithionite solution. 
The enzyme solution was placed in a cuvette with a rubber stopper, it was made 
oxygen-free by using the vacuum-gas method (gas used for purging was 
nitrogen). The anaerobic dithionite solution was then carefully added to the 
oxygen free enzyme solution in a ratio of 5:1(dithionite: enzyme). The spectrum 
was then measured immediately to check if the enzyme was reduced. There was a 
shift in the Soret band from 414nm to 411nm (shown in Figure 33) as expected. 
Carbon monoxide gas was bubbled through the solution for five minutes using a  
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Figure 33: Absorption spectra on adding dithionite (shift from 414nm to 411nm) 
 
 
needle to maintain the anaerobicity; addition of carbon monoxide didn’t show the 
expected shift in the Soret band from 411nm to 446nm. 
3. 8 Assay using the camphor bound cytochrome P450cam 
The cytochrome P450cam isolated was not in the camphor bound form. To 
cytochrome P450cam at pH 7.4 (pH was adjusted by adding 50Mm Tris HCl 
buffer) KCl and camphor were added such that the final enzyme solution had 
0.1M KCl and 5mM camphor. The absorption spectrum of this solution was 
measured from 200nm to 700nm. The absorption spectrum was expected to shift 
from 414nm to 392nm; instead the shift was from 414nm to 405nm (as seen in 
Figure 34). 
Then dithionite was added anaerobically as before to the camphor bound enzyme 
and the spectrum were measured but it didn’t show the expected shift of the  
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Figure 34: Absorption spectra of the Oxidized P450cam containing 5mM camphor 
Soret band to 409nm (Figure 35). Neither did bubbling carbon monoxide 
through the dithionite reduced solution shift the peak to 446nm (Figure 36). 
3.9 Control experiment 
 Escherichia coli (DH5α) cells containing pKSD6-1 were grown in LB containing 
50µg/mL ampicillin and 30µg/mL chloramphenicol at 37°C overnight. These 
cells showed no growth. Upon verification it was found that these Escherichia coli  
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Figure 35: Absorbance spectra of oxidized P450cam and camphor with dithionite 
 
 
 
 
 
 
 
Figure 36: Absorbance spectra of P450cam+ Camphor+ Dithionite +Carbon 
monoxide 
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cells containing the pKSD6-1 plasmid had always been grown only in 50µg/mL 
ampicillin. Therefore the control cells were grown in LB containing only. 
50µg/mL ampicillin whereas the recombinant cell culture (Escherichia coli 
containing pKSD6-1 +P450) was grown in LB (Luria Broth) containing 
50µg/mL ampicillin and 30µg/mL chloramphenicol and the protein was 
expressed in each culture according to the same protocol as before. An 
absorption spectrum was taken for the protein extract from each cell culture 
(Figure 37), which proves that only the recombinant pKSD6-1+CYP101 cells 
produce a peak at 420nm. 
As seen from Figure 37 it is evident that the control doesn’t produce the 
cytochrome P450cam enzyme and therefore the recombinant pKSD6-1+CYP101 
DNA contain the cloned P450cam gene. To make it certain that the control 
doesn’t produce any peak at all, the protein extract from the cell culture was 
concentrated to thrice its original concentration and its absorption spectra was 
again measured (shown in Figure 38). 
3.10 Analysis of Recombinant DNA. 
It was also necessary to prove the presence of the cytochrome P450cam gene in the 
recombinant plasmid using molecular biology tools like restriction and gel  
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 Figure 37: Absorption spectra of the protein extract control and recombinant 
culture 
 
Figure 38: Difference in spectra of control (concentrated) and recombinant 
protein extract  
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analysis. Isolation of the recombinant pKSD6-1 containing P450cam was a difficult 
task. The DNA couldn’t be isolated using the standard boiling prep protocol. 
After many trials the recombinant DNA was isolated .The uncut band was run on 
the gel and its size was observed to be 20kbp (seen in Figure 39). When this 
recombinant DNA was restricted with NotI, ApaI and BspEI, NotI +BspeI, 
NotI+ApaI the solutions were analyzed on an agarose gel (shown in Figure 40), 
they showed no DNA at all. Repetitive attempts produced similar results. This led 
to the conclusion that the DNA might have been degraded by Dnase activity. 
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Figure 39: Agarose gel showing the 
uncut recombinant pKSD6-1+P450 at 
20kbp. 
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 Figure 40: Restriction digests of 
recombinant pKSD6-1+P450 with 
various enzymes.  
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C h a p t e r  4  
ANALYSIS AND DISCUSSION 
 
4.1 Recombinant Protein Expression in Escherichia coli   
The Gram-negative bacterium Escherichia coli is the most widely- used organism 
for producing heterologous proteins because of its ability to grow rapidly and at 
high density on inexpensive substrates, its well-characterized genetics and the 
availability of a large number of cloning vectors. The unique and subtle structural 
features of the gene sequence, the stability and the translational efficiency of the 
mRNA, the ease of protein folding, degradation of the protein by host cell 
proteases, major differences in codon usage between the foreign gene and native 
Escherichia coli and potential toxicity of the protein to the host Escherichia coli are 
some of the probable reasons why a gene might not be efficiently expressed in 
Escherichia coli. [37, 38] 
Several elements need to be considered for efficient expression of genes and the 
highest level of protein synthesis. Figure 41 below shows the essential 
architecture of an Escherichia coli expression vector. The promoters in Escherichia 
coli are 10-100bp upstream of the ribosome-binding site (RBS) and the promoter  
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 Figure 41: Schematic presentation of 
the salient features and sequence 
elements of a prokaryotic expression 
vector. [38]  
is under the control of a regulatory gene (R), which may be present either on the 
vector or on the host chromosome. The promoters of Escherichia coli consist of a 
hexanucleotide sequence that is about 35bp upstream of the transcription 
initiation base (-35 region), separated by a spacer region from another 
hexanucleotide sequence (-10 region). [38] 
The RBS (ribosome binding site), which spans approximately 54 nucleotides 
bound by positions –35 )2(± and +19 and +22 of the mRNA coding sequence is 
located downstream of the promoter. The Shine-Dalgarno (SD) site interacts 
with the 3′ end of the 16SrRNA during translation initiation. The range of the 
distance between the SD site and the initiation codon should be 5-13bp. The 
transcription terminator is located downstream of the coding sequence and serves 
as a signal to terminate 
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transcription. Vectors also contain a gene that confers resistance on the host to 
aid in plasmid selection and propagation. [38] 
4.2 Requirements for expression of cytochrome P450cam in Escherichia coli 
The active enzyme cytochrome P450cam requires the proper coordination of the 
non-covalently bound heme, which must be produced and incorporated into the 
nascent polypeptide. 
For successful synthesis of cytochromeP450cam in Escherichia coli 
• The gene encoding the particular P450 should be cloned downstream of 
an efficient promoter and the ribosome-binding site should be present on 
a multicopy number plasmid. 
• An efficient promoter should direct the synthesis of hybrid mRNA 
molecules that contain signals immediately upstream of the initiation 
codon that directs Escherichia coli ribosomes to initiate translation of the 
inserted gene sequence. 
• On being translated the nascent polypeptides should bind a molecule of 
heme and fold into the final tertiary structure. 
 81
• Production of the recombinant protein in Escherichia coli places additional 
burden on the cellular metabolism in Escherichia coli and therefore it is 
necessary for the cell to produce the proteins (Gro ES and Gro EL) 
required for folding. [39] 
4.3 Synthesis of cytochrome P450cam enzyme in Escherichia coli using the 
vector pKSD6-1 
Cytochrome P450cam gene was cloned at the ApaI site in the multiple cloning site 
of the shuttle vector pKSD6-1. The MCS (multiple cloning site) of pKSD6-1 has 
been derived from the pBluescript II KS (-) plasmid. [18] Since the entire 
sequence of the pKSD6-1 is not known (not given in [18]) the sequence of the 
gene-containing fragment of recombinant pKSD6-1+CYP101 was constructed 
using some of the information that is given in [18]. First, the 3-TOPO+CYP101 
sequence was constructed using pCR2.1 TOPO and the CYP101 sequence (the 
gene had appropriate primer ends). From this sequence the ApaI-ApaI fragment 
containing the cytochrome P450cam gene was taken and was added at the ApaI 
site in the MCS of pBluescript II KS (-)(Statagene). The various factors such as 
the promoter, the Shine-Dalgarno sequence etc that affect the expression of the 
protein in Escherichia coli were analyzed with the above sequence. 
When the 5′ApaI-ApaI 3′ was inserted into the ApaI in the MCS of the shuttle 
vector, the cytochrome P450 gene was found to be expressed under the T7 
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promoter. Some of the essential features for expression of the protein were found 
to be missing in the sequence. Though the -10 consensus sequence (TATA) was 
present, the -35 consensus sequence (TTGACA) was not as it should be, the very 
important Shine-Dalgarno sequence was not present between the promoter and 
gene and finally when this sequence was checked for ORFs (Open reading 
frames) using NEB cutter the protein being translated by the gene was 
451aa(amino acid residues) instead of 414aa and the protein start codon was 
TTG(present on the vector) instead of ATG (present on the plasmid). These 
factors led to the conclusion that the gene might have been ligated in the reverse 
direction. 
The inverse sequence of the 5′ApaI-ApaI 3′ was obtained from [40] and inserted 
into the ApaI site of the shuttle vector (sequence given as Figure 42). This 
ligation puts the gene under the control of the T3 promoter. The sequences when 
analyzed using the NEB cutter showed the production of 415aa with an ATG 
start codon. The way in which the sequence was ligated causes the 3′-5′ strand to 
be the coding gene (Figure 43). The distance between the start codon ATG and 
the T3 promoter was found to be only 26 nucleotides. The -10 sequence and -35 
sequence for the lac promoter in Escherichia coli are 5′TATGTT 3′ and 5′TTTACA 
3′ since the gene was ligated in the inverse direction the-10 and the -35 regions 
found on the 5′-3′ of the gene are 5′ AACATA 3′ and 5′ TGTAAA 3′; these are 
situated 69bp (base pairs) and 93bp upstream of the promoter on the coding gene  
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CTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTAC
ACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTC
CCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCA
AAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTG
ACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCG
GTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAAC
AAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAAC
TGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTG
CAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAG
CGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAG
TGGATCCCCCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGAGGGGGGGCCCT
CTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCGCCCTTCATGAGCTCAAG
CTTTGGATAGCGGTGGTAGGTGATGGGGAATTACCGTCGCATCCCCCACCAACCGGATATTGCCTTCC
CAGCCGCTGGCGCGCAGGCCGAAGGCGACCTCAACGCCAGCCAGTCCGGTACCGACGATGACCACGTT
GTCGTTTGCGTTCACTTAGCACGCACTCCCATGTGTTTATACCGCTTTGGTAGTCGCCGGATCCCAGAC
CAGAGGGAGTGCCTGCACGCCGCTGACGATGCCGCTCTTGTGCTGAATCTGGGCACCCGGGGCAATG
GAGAAGTCAGGAATCCTGGTCAGCCATTCCTTGAGGGTGACGATGATTTCCCGGCGGGCCAGGTGCT
GGCCAAGGCACAGATGGCTGCCGTGGCCAAAGGTGGTGTGTGAAACCTTTTGGCGACTGAAGTCGAC
GTGCATCGGGCAGGCGTTTTCGCGCTCATCCAGGCCAGACAGCATCTGCGGTAGCAGGATCTGGTCAC
CTTTCTTCAGTTGCACGCCATGAAACTCGTAATCGGAGGTGAGGATGCGGCCATCGGCAACCAGCGAG
AAGCGCCGGAGTAGTTCCTCGCAAGCGGCTGGAATACGCTCGGGACGCTCGATCAGCTCCTGGCGAT
GCTCCGGGCTTTTGGCCAGGAACTCCATGCTGAAGCTGAGGAAATTGACCACCGTATCCAGGCCGCCG
ACCAGTAACAGGCCACACATCCTCTTGGCTTCGTCACTGGTGATCGGTCGCCCATTGACCTGGCCGTTG
GCAACGATGCTGATAGCGTCGGTTCCCGGCTTCTGCCTGCGTTGCTCGATGATCGGTATCAGATAGTC
GTAGAGCGCCTCCTTGGCCTCTGCGAAGGTCATGCTGCCATCCGGACGGGTCATCTGATCCGTTAGGT
ATTTCAAGTGCGGGATATCTTCTTCCGGTAGACCTGCGAGCAGCATGAAGATGCGTATCGGGAAGGGT
TCGGCGTAGTCCTCGGTGAAGTTGCACTGTCCTTGCGGGCGCAGGCTCTCGATCAGCGAGCAGGCCA
GCTCCTGGATCCGGTTCTCCAGCTTATCCACCACCGGCATGCCAACCACTTGGTTGGCCAGCGCACGAA
ACTGGCGCTGCTCGGGCGGATCCATCGAGGTGGGAATGAAGTCGTAGGCTTCGCCGGCTTCACGAGG
GATGAACGGGCACTCGCTGGAAAAGTGGCGGTAATCTTCATAGGCCTCACGGATCAGTTGGCCGCGA
GTGGCGATCCAGTGTCCGCCGTTGCAGCGAGTCCACACCAGATCCGGTACGTTTGATTCTTGCAGAAC
TGCCCAGGCCTCCTGCACGCCGGCAGACAGATTCGACGGATTGTACATGTCGAAGTCGAATACCAGGT
GCTCTGGCACATGGGGTGGCAGAGGGGCAAGATTGGCGTTGCTTTGTATGGTTTCAGTCGTCATTGT
GGGCCCGGTACCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCAT
AGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGT
GTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCC
AGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCG
TATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGG
TATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATG
TGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCT
CCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTAT
AAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCG
GATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCA
GTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCC
ACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTA
ACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCA
GTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCT
TTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAA
TGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCG
TCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGAC
CCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGG
TCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCC
AGTTAATAGTTTGCGCAACGT 
CCCTTTAGTGAGGGTTAATT-T3 Promoter ,GGGCCC-ApaI site,TTA   C-terminal, 
AACATA  -10 SITE,CAT   N-terminal TGTAAA   -35 SITE 
 
 
Figure 42: Sequence of a part of pKSD6-1 containing the CYP101 gene in its 
MCS  
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Figure 43: The direction of translation 
of the protein 
 
respectively. The Shine-Dalgarno (SD) sequence for the lac I is 5′ GGUGGU 3′ 
which should be found on the sequence in Figure 42 as 5′ ACCACC5′ -3′ between 
the promoter and the coding gene, but such a sequence was not present. This 
suggests that there might be another possible SD sequence as they vary from one 
promoter to another. When the sequence given in Figure 42 was analyzed in 
NEB cutter for ORFs, the sequence encoding the cloned gene was found to 
produce a protein of 415 aa (Figure 44). From the above analysis it is clear that 
the enzyme being produced is a P450.  
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MTTETIQSNA NLAPLPPHVP EHLVFDFDMY NPSNLSAGVQ 
EAWAVLQESN 
VPDLVWTRCN GGHWIATRGQ LIREAYEDYR HFSSECPFIP 
REAGEAYDFI 
PTSMDPPEQR QFRALANQVV GMPVVDKLEN RIQELACSLI 
ESLRPQGQCN 
FTEDYAEPFP IRIFMLLAGL PEEDIPHLKY LTDQMTRPDG 
SMTFAEAKEA 
LYDYLIPIIE QRRQKPGTDA ISIVANGQVN GRPITSDEAK 
RMCGLLLVGG 
LDTVVNFLSF SMEFLAKSPE HRQELIERPE RIPAACEELL 
RRFSLVADGR 
ILTSDYEFHG VQLKKGDQIL LPQMLSGLDE RENACPMHVD 
FSRQKVSHTT 
FGHGSHLCLG QHLARREIIV TLKEWLTRIP DFSIAPGAQI 
QHKSGIVSGV 
QALPLVWDPA TTKAV 
 
Figure 44: 415 aa sequence encoded 
by the gene. 
4.4 The chloramphenicol resistance gene  
The multitude of attempts made at cloning the cytochrome P450cam gene from 3-
TOPO+CYP101 into pKSD6-1 were met with consistent failures. It was always 
presumed that there was something wrong with the vector: insert ratio and lots of 
attempts were made in trying to improve the quantities and the ratios of the 
vector and insert used whereas in fact the problem might have actually been with 
the expression of the resistance genes in the vector. 
While performing the control experiment it was observed that the Escherichia coli 
(DH5α) cells containing the shuttle vector pKSD6-1 (without the CYP101 gene) 
was unable to grow in a LB containing both chloramphenicol and ampicillin, 
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though it has both the resistance genes as seen in Figure 16.But the same cells 
were capable of growing in LB containing only ampicillin.  
The Escherichia coli (DH5α) cells containing only pKSD6-1 were cultured 
previously to isolate vector DNA. This vector DNA was used in constructing the 
recombinant plasmid of pKSD6-1 containing P450cam. The cells of the single 
positive clone isolated after transforming the recombinant plasmid initially took 
about 48hrs to grow in media containing both antibiotics. 
Requirements of some gene products change over time. The need for enzymes in 
certain metabolic pathways wax and wane as the food sources change or are 
depleted. From the above observations, it is possible that the chloramphenicol 
resistance gene was lost due to a possible mutation. It was cultured only in media 
with ampicillin in the lab for over a year and it could have been lost due to a lack 
of selective pressure over generations. This could be one of the main reasons why 
the clones didn’t grow on agar plates containing ampicillin and chloramphenicol. 
4.5 Spectral Analysis of the P450cam enzyme from the recombinant plasmid. 
The oxidized enzyme in the camphor-free form has two absorption maxima; one 
at 414nm and the other at 550nm instead of the expected maxima at 418 and 
535nm, the other expected peaks at 280nm and 570nm were not observed. Also 
the absorption maxima did shift from 414nm to 411nm when reduced with 
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dithionite (Na2S2O4) and gassed with carbon monoxide. Camphor binding assay 
showed absorption maxima shift to 405nm instead of the expected 392nm, but 
the other shifts were not observed. 
Theoretically the absorption spectra of the oxidized camphor-free form of the 
cytochrome P450cam enzyme has α andβ bands at 571nm and 538nm, the Soret 
band is 417nm, a γ band at 365nm and aromatic acid content is seen at 280nm 
with a shoulder at 290nm, in the experiments only the Soret band was observed 
at 414nm and instead of the two α and β bands a single peak was observed at 
550nm. 
The presence of the Soret band at 414nm confirms the presence of the heme 
protein, cytochrome P450cam. Actually both α and β bands fuse into a single band 
at 550nm because of the formation of a complex between the reduced 
cytochrome P450cam and carbon monoxide. The single band formed at 550nm in 
the experiments. The other bands like γ band at 365nm and others could not be 
observed because the sample was not very pure. Addition of camphor to the 
enzyme solution shifts the Soret band to 405nm instead of 392nm.Whereas 
reduction with dithionite and later addition of carbon monoxide didn’t show the 
expected bands. 
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4.6 Possibility of the enzyme being cytochrome P420 
Cytochrome P420 is an inactive form of cytochrome P450 that can be formed 
from all types of known P450s by incubation with acetone or exposure to high 
temperature and pressure. The P420 has a Soret absorption band at 420nm and 
the α and β bands coalesce into a single band in the α band region (at571nm), on 
adding sodium dithionite the Soret band shifts to 423nm and the α band is 
at556nm. Soret absorption of the ferrous-CO complex is more intense with a 
420nm maximum. Addition of a substrate or inhibitor doesn’t alter the P420 
absorption bands. P420 is a collective term as some forms can be converted back 
into the active enzyme and show the ferrous-CO spectrum of the native protein 
while others cannot. Also the spectra of the P420 samples can vary in the Soret 
and α regions. [41] 
The Soret band at 414nm, the coalescence of the α and β bands in a single band 
at 550nm observed in the results suggest the presence of P420, the inactive form 
P450cam in the enzyme solution. But there is no shift in the Soret or the α band 
on reducing the enzyme with dithionite; this could be because the reduction was 
not done under appropriate (anaerobic) conditions. Again addition of camphor to 
the enzyme solution shouldn’t produce a shift in the absorption bands if the 
enzyme were P420, but the enzyme solution did show a shift in its Soret band 
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from 414nm to 405nm on addition of camphor, so the enzyme may not be a 
P420.  
4.7 Other Possible reasons for the lack of enzymatic activity 
Lack of proper thiolate coordination: The heterolytic oxygen scission of the heme 
bound oxygen is supposed to be facilitated by the strong electron donation of the 
anionic thiolate axial heme ligand. The inactivated form P420 lacks such thiolate 
coordination. Any mutation at the Cys357 residue is bound to destroy the heme 
environmental structure resulting in the loss of enzymatic activity. 
Errors in the PCR: While producing the CYP101 gene from PCR using the 
pCWori+CYP101 as template there is a possibility that there were some 
mutations because of the limited fidelity of the Taq polymerase enzyme. If there 
were any such errors these have not been investigated in any way. Even a single 
mutation in the gene can alter the amino acid residues produced, hence the 
protein and thereby its spectral characteristics. 
The enzyme is being produced in an inactive form, the causes for the lack of 
activity in the enzyme may be because of some deleterious mutation in the gene 
encoding for the enzyme. Also the disappearance of chloramphenicol resistance 
activity from the shuttle vector played an important role, in the sense better 
clones could have been isolated if this problem was observed earlier. 
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C h a p t e r  5  
SUMMARY AND FUTURE WORK 
5.1 Summary 
The fundamental idea of the project was to clone the CYP101 gene into the 
Rhodococcus-Escherichia coli shuttle vector pKSD6-1, so that the enzyme can be 
expressed in Rhodococcus and it can be tailored using random mutagenesis to act on 
the carcinogenic PAHs, which are not readily degraded by naturally occurring 
enzymes or  on the alkanes for producing commercially useful alcohols. 
The cytochrome P450cam (CYP101) gene was produced with appropriate ends 
using pCWori +CYP101 as a template for polymerase chain reaction (PCR), and 
employing suitable primers that were designed using sites ApaI and SacI for the 
forward and the backward primers respectively. Direct cloning of the PCR 
product into the shuttle vector pKSD6-1 was not possible, because SacI site was 
found to have three restriction sites on the shuttle vector pKSD6-1. It was 
therefore necessary to find an alternative way to clone the CYP101 gene into the 
shuttle vector pKSD6-1. 
The pCR 2.1 TOPO is a commercially available vector with ‘T’ endings into 
which the cytochrome P450cam gene that was produced from the PCR with 
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P4501F and P4501R primers was cloned. This recombinant plasmid of 
TOPO+CYP101 was transformed into Escherichia coli. The positive clones were 
restricted with NotI enzyme to test for the presence of the CYP101 gene. The 
presence of a 5.4 kbp product from the colony 3 during gel analysis confirmed 
the presence of the gene 
ApaI site was found to be the only restriction site that was compatible for cloning 
the cytochrome P450cam gene from 3-TOPO+CYP101 to pKSD6-1. The gene 
was restricted with ApaI enzyme from 3-TOPO+CYP101 and was cloned into 
pKSD6-1 that was also restricted with ApaI and the recombinant pKSD6-
1+CYP101 plasmid was transformed into Escherichia coli (DH5α). Only one 
positive clone was found, which was grown in suitable medium containing the 
suitable antibiotics, chloramphenicol and ampicillin and stored. 
The cytochrome P450cam enzyme was expressed from the aforementioned 
positive clone containing the P450cam gene in pKSD6-1. Spectral analysis of the 
protein extract revealed an enzyme showing a peak at 414nm instead of the 
expected 417nm and one at 550nm. Carbon monoxide binding assay did not 
show the expected shift in the peaks. The camphor-bound enzyme showed a shift 
in the Soret band from 414nm to 405nm instead of the expected 392nnm. 
The results from the camphor and the carbon monoxide binding assays suggest 
that the enzyme present may be the inactive form of the cytochrome P450cam 
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enzyme; cytochrome P420 or the cytochrome P450cam enzyme with some 
mutation. The DNA analysis of the recombinant pKSD6-1+CYP101 plasmid 
was unsuccessful. Difficulties in the isolation of the recombinant DNA and 
degradation of the DNA during restriction analysis have caused speculation that 
the degradation might be a result of Dnase action. 
5.2 Future work 
The work presented in this thesis is just a step towards achieving the final goal of 
expressing cytochromeP450cam gene in a Rhodoccocus-Escherichia coli shuttle vector 
and tailoring the enzyme to act on the hydrocarbons of environmental and 
industrial interest. The first step towards achieving this end would be to generate 
a better clone than the available one. 
In order to generate a better clone, it is essential to know more about the existing 
one. Therefore sequencing the present clone would provide a lot of information. 
From the sequence it could be found out if the gene was inserted properly and 
whether there are any mutations in the gene. If there are no mutations present in 
the gene then experiments should be carried out to investigate why the enzyme is 
not exhibiting its characteristic spectral properties.  
Also the sequence of the clone will give information about the chloramphenicol 
resistance gene. Whether or not another attempt should be made at cloning the 
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cytochrome P450cam gene into pKSD6-1 will depend on the results of the 
aforementioned analysis of the existing clone. Then the better clone can be 
transformed into Rhodococcus cells through electroporation, the protein should be 
expressed and enzyme assays should be performed to test the presence of the 
cytochrome P450cam. If the enzyme is present then it can be tested on 
polyaromatic hydrocarbons and alkanes for its activity and later engineered to suit 
the particular process. 
 
 
 
 
 
 
 
 
 
 94
BIBLIOGRAPHY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 95
 
1. David L. Nelson, Michael M. Cox. Lehninger: Principles of Biochemistry. 
(2000) Third Edition, Worth Publishers, 782-783. 
2. Stephen G. Bell, Erica Orton, Helen Boyd, Julie-Anne Stevenson, Austin 
Riddle, Sophie Campbell and Luet-Lok Wong. Engineering cytochrome 
P450cam into an alkane hydroxylase. (2003) Dalton Transactions, 11: 2133-
2140. 
3. Benjamin P. Unger, I.C. Gunsalus and Stephen G. Sligar. Nucleotide 
sequence of the Pseudomonas putida cytochrome P-450cam gene and its expression in 
Escherichia coli. The Journal of Biological Chemistry, 1986, 261: 1158-1163. 
4. Harald Bredholt, Per Bruheim, Martin Potocky, and Kjell Eimhjellen. 
Hydrophobicity development, alkane oxidation, and crude-oil emulsification in a 
Rhodococcus species. (2002) Canadian Journal of Microbiology, 48: 295-304. 
5. Philip A. Lessard, Xian M. O′ Brien, Devin H Currie and Anthony J 
Sinskey. pB264, a small, mobilizable, temperature sensitive plasmid from 
Rhodococcus.http://www.biomedcentral.com/1471-2180/4/15. 
6. Joseph Sambrook, David W. Russel. Molecular cloning: a laboratory manual. 
Third Edition, Cold Spring Harbor Laboratory Press, New York. Chapter 
8, 8.18-8.113. 
 96
7. Caroline S. Miles, Tobias W. B. Ost, Michael A. Noble, Andrew W. 
Munro, Stephen K. Chapman. Protein engineering of cytochromes P-
450.Biochimica et Biophysica Acta (2000), 1543: 383-407. 
8. http://drnelson.utmem.edu/CytochromeP450.html 
9. F. Peter Guengerich. Cytochrome P450.Enzyme systems that metabolize drugs 
and other xenobiotics. Edited by C. Loannides. (2002) John Wiley & Sons 
Ltd, 34-65. 
10. Burkhard Schiffler and Rita Bernhardt. Bacterial (CYP101) and mitochondrial 
P450 systems-how comparable are they? Biochemical and Biophysical research 
communications. (2003) 312: 223-228. 
11. Max J. Cryle, Jeanette E. Stok and James J. De Voss. Reactions catalyzed by 
bacterial cytochromes P450.Australian Journal of Chemistry. (2003) 56: 749-
762. 
12. C. A. Yu and I.C. Gunsalus. Cytochrome P450cam.crystalline structure and 
properties. The Journal of Biological Chemistry (1974), 249: 94-101. 
13. Julian A. Peterson. Camphor binding Pseudomonas putida cytochrome 
P450.Archives of Biochemistry and Biophysics (1971), 144: 678-693. 
 97
14. Thomas L. Poulos. The crystal structure of cytochrome P450cam.Cytochrome P-450: 
Structure, Mechanism and Biochemistry (1986), Chapter 13.  
15. Thomas L. Poulos, Barry C. Finzel, Andrew J. Howard. High- resolution 
crystal structure of cytochrome P450cam.Journal of molecular biology (1987), 195: 
687-700. 
16. Susan Sondej Pochapsky, Thomas C. Pochapsky and Julie W. Wei. A 
model for effector activity in a highly specific biological electron transfer complex: the 
cytochrome P450cam-Putidaredoxin couple. Biochemistry (2003), 42: 5649-5656. 
17. Ilme Schlichting, Joel Berendzen, Kelvin Chu, Ann M. Stock, Shelley A. 
Maves, David E. Benson, Robert M. Sweet, Dagmar Ringe, Gregory A. 
Petsko, Stephen G. Sligar. The catalytic pathway of cytochrome P450 cam at 
atomic resolution. Science (2000), 287:1615-1622. 
18. Claude Denis-Larose, Helene Bergeron, Diane Labbe, Charles W. Greer, 
Jalal hawari, Matthew J. Grossman, Bruce M. Sankey and Peter C. K. Lau. 
Characterization of the basic replicon of Rhodococcus plasmid pSOX and development 
of a Rhodococcus-Escherichia coli shuttle vector. (1998) Applied and 
Environmental Microbiology, 64: 4363-4367. 
 98
19. Hideo Shimada, Shingo Nagano, Hiroshi Hori, Yuzuru Ishimura. 
Putidaredoxin-cytochrome P450cam interaction. (2001) Journal of 
Inorganic biochemistry, 83: 255-260. 
20. Matthew M. Purdy, Laura S. Koo, Paul Oritz de Montellano and Judith P. 
Klinman. Steady state kinetic investigation of cytochrome P450cam: interaction with 
redox partners and reaction with molecular oxygen. (2004) Biochemistry, 43: 271-
281. 
21. Zhoupeng Zhang, Ole Sibbesen, Roy A. Johnson and Paul Oritz de 
Montellano. The substrate specificity of cytochrome P450cam. (1998) Bioorganic 
and medicinal chemistry, 6: 1501-1508. 
22. Ole Sibbesen, Zhoupeng Zhang and Paul Oritz de Montellano. Cytochrome 
P450cam substrate specificity: relationship between structure and catalytic oxidation of 
alkylbenzenes. (1998) Archives of biochemistry and biophysics, 353: 285-
296.  
23. Jonathan P. Jones, Ellen J O′ Hare and Luet-Lok Wong. Oxidation of 
polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450cam). 
2001, European Journal of Biochemistry, 268: 1460-1467. 
24. Stephen G. Bell, Julie Anne Stevenson, Helen D. Boyd, Sophie Campbell, 
Austin D. Riddle, Erica L. Orton and Luet-Lok Wong. Butane and propane 
 99
oxidation by engineering cytochrome P450cam. (2002) Chemical Communications, 
5: 490-491. 
25. Julie-Anne Stevenson. Engineering molecular recognition in alkane oxidation 
catalyzed by cytochrome P450cam.1998, New Journal of Chemistry, 6: 551-552. 
26. Darren P. Nickerson et al. The catalytic activity of cytochrome P450cam towards 
styrene oxidation is increased by site-specific mutagenesis.1997, FEBS Letters, 405: 
153-156. 
27. Julie-Anne Stevenson, Andrew C.G. Westlake, Catherine Whittock and 
Luet-Lok Wong. The catalytic oxidation of linear and branched alkanes by 
cytochrome P450cam. 1996, Journal of American Chemical Society, 118: 
12846-12847. 
28. Charles F. Harford-Cross, Angus B. Carmicheal, Fiona K.Allan, Paul A. 
Englad, Duncan A. Rouch and Luet-Lok Wong. Protein engineering of 
cytochrome P450cam (CYP101) for the oxidation of polycyclic aromatic hydrocarbons. 
(2000) Protein Engineering, 13 : 121-128. 
29. Paul A. England, Charles F. Harford Cross, Julie Anne Stevenson, 
Duncan A. Rouch and Luet-Lok Wong. The oxidation of naphthalene and 
pyrene by cytochrome P450cam. (1998) FEBS letters, 424: 271-274. 
 100
30. http://www.brunel.ac.uk/depts/bl/project/genome/moltec/vectors/sh
uttle.htm 
31. T.Matsui, K.Hirasawa, J.Konishi, Y.Tanaka, K.Maruhashi and R.Kurane. 
Microbial desulfurization of alkylated dibenzothiophene and alkylated benzothiophene 
by recombinant Rhodococcus sp. strain T09. (2001) Applied Microbiology and 
Biotechnology, 56: 196-200. 
32. R. Kalscheuer, M. Arenskotter and A. Steinbuchel. Establishment of a gene 
transfer system for Rhodococcus opacus PD630 based on electroporation and its 
application for recombinant biosynthesis of poly (3-hydroxyalkanoic acids). (1999) 
Applied Microbiology and Biotechnology, 52: 508-515. 
33. Jan Desomer, Patrick Dhaese and Marc Van Montagu. Transformation of 
Rhodococcus fascians by high-voltage electroporation and development of R.fascians 
cloning vectors. (1990) Applied and Environmental Microbiology, 56: 2818-
2825. 
34. M.E. Vogt Singer and W.R. Finnerty. Construction of an Escherichia coli-
Rhodococcus shuttle vector and plasmid transformation in Rhodococcus spp. (1988) 
Journal of Bacteriology, 170: 638-645. 
 101
35. Julie A. Gegner. Signal transduction in bacteria: CheW forms a reversible complex 
with the protein kinase CheA. (1991) Proccedings at the national academy of 
science USA, 88: 750-754. 
36. http://www.invitrogen.com/content.cfm?pageid=9716 
37. Francois Baneyx. Recombinant protein expression in Escherichia coli. (1999), 
Current Opinion in Biotechnology, 10:411-421. 
38. Savvas C. Makrides. Stratergies for achieving high-level expression of genes in 
Escherichia coli. (1996) Microbiological Reviews, 512-538. 
39. Henry J. Barnes. Maximizing the expression of eukaryotic cytochrome P450s in 
Escherichia coli. (1996) Methods in Enzymology, 272: 3-14. 
40. http://www.entelechon.com/eng/seqinv.html 
41. C. A. Yu and I. C. Gunsalus. Cytochrome P450cam II Interconversion with P420. 
(1972) The Journal of biological chemistry, 249: 102-106. 
42. Julian A. Peterson, Matthew C. Lorence and Bilal Amarneh. 
Putidaredoxin Reductase and Putidaredoxin. Cloning, sequence determination 
and heterologous expression of the proteins. (1990) The Journal of biological 
chemistry, 265: 6066-6073. 
 102
43. Paul A. England, Charles F. Harford Cross, Julie Anne Stevenson, 
Duncan A. Rouch and Luet-Lok Wong. The oxidation of naphthalene and 
pyrene by cytochrome P450cam. (1998) FEBS letters, 424: 271-274. 
 
 
 
 
 
 
 
 
 
 
 
 
 103
VITA 
Sirisha Chada was born in Visakhapatnam, India on the 16th of January 1981. She 
completed her schooling at St.Joseph’s Girls’ High School, Visakhapatnam in 
1996 and her intermediate from B.V.K Junior College in 1998. She had great 
experiences at both the places. Her life at school has influenced her to become 
the person that she is today.  
Sirisha’s career in engineering started in 1998 when she enlisted herself as a 
student in the Chemical Engineering department at Andhra University, 
Visakhapatnam. She graduated in June 2002. Her interest in the field of 
Biochemical Engineering has driven her to pursue her Masters in Chemical 
Engineering at the University of Tennessee, Knoxville. She will be graduating in 
August 2004. 
 
 
 
 
 
 
 104
